<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2026.1742817</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Multiscale physiologically-based model of age-dependent CD4+ T-lymphocyte homeostasis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kulesh</surname><given-names>Victoria</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2302467/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Peskov</surname><given-names>Kirill</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/582228/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Helmlinger</surname><given-names>Gabriel</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/719468/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Bocharov</surname><given-names>Gennady</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/77618/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Research Center of Model-Informed Drug Development, Sechenov First Moscow State Medical University</institution>, <city>Moscow</city>,&#xa0;<country country="check-value">Russia</country></aff>
<aff id="aff2"><label>2</label><institution>Marchuk Institute of Numerical Mathematics of the Russian Academy of Sciences (INM RAS)</institution>, <city>Moscow</city>,&#xa0;<country country="check-value">Russia</country></aff>
<aff id="aff3"><label>3</label><institution>Lomonosov Moscow State University</institution>, <city>Moscow</city>,&#xa0;<country country="check-value">Russia</country></aff>
<aff id="aff4"><label>4</label><institution>Modeling &amp; Simulation Decisions FZ-LLC</institution>, <city>Dubai</city>,&#xa0;<country country="ae">United Arab Emirates</country></aff>
<aff id="aff5"><label>5</label><institution>Quantitative Medicines Consulting</institution>, <city>Boston</city>, <state>MA</state>,&#xa0;<country country="us">United States</country></aff>
<aff id="aff6"><label>6</label><institution>Institute for Computer Science and Mathematical Modelling, Sechenov First Moscow State Medical University</institution>, <city>Moscow</city>,&#xa0;<country country="check-value">Russia</country></aff>
<aff id="aff7"><label>7</label><institution>Moscow Center of Fundamental and Applied Mathematics at INM RAS</institution>, <city>Moscow</city>,&#xa0;<country country="check-value">Russia</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Victoria Kulesh, <email xlink:href="mailto:viktoriaan37@gmail.com">viktoriaan37@gmail.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-04">
<day>04</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1742817</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>31</day>
<month>12</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Kulesh, Peskov, Helmlinger and Bocharov.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Kulesh, Peskov, Helmlinger and Bocharov</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-04">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>To develop a mechanistic physiologically-based model describing CD4<sup>+</sup> T-lymphocyte homeostasis across the human lifespan, incorporating maturation, differentiation, migration aspects and the impact of age on distinct cell subpopulations.</p>
</sec>
<sec>
<title>Methods</title>
<p>A stepwise modeling approach was implemented by integrating published quantitative data on CD4<sup>+</sup> T-cell concentration in blood and various tissues for narrowly defined age ranges, together with experimental kinetic parameters. The homeostatic CD4<sup>+</sup> T-lymphocyte kinetics model was represented as a system of ordinary differential equations for four thymocyte subpopulations and six CD4<sup>+</sup> T-lymphocyte subpopulations, incorporating five physiological compartments: the thymus, blood, lymphoid tissue, the gastro-intestinal tract, and lung tissue. A series of empirical functions was sequentially tested to describe age-related changes in homeostasis. Reciprocal cellular feedback functions were assessed for incorporation in the model, as an alternative to age-dependent functions. An extensive set of model evaluations was performed, including model validation on total and memory CD4<sup>+</sup> T-cell concentrations, simulations of homeostasis perturbations following thymectomy, and global sensitivity analysis, to determine the processes most influential in shaping CD4<sup>+</sup> T-cell homeostasis.</p>
</sec>
<sec>
<title>Results</title>
<p>Age-related shifts in proliferation of na&#xef;ve and activated cells, differentiation of memory subsets, survival of recent thymic emigrants (RTE) and migration aspects of CD4<sup>+</sup> T-cells &#x2013; together with reduced thymic output &#x2013; were identified as key determinants of immune homeostasis. Sensitivity analyses showed that thymocyte and na&#xef;ve cell homeostasis drives early differentiation stages, whereas clonal expansion dominates memory and effector cell maintenance, with the influence of all processes declining with age. Although increased na&#xef;ve T-cell proliferation and reduced RTE death may partially compensate for thymic loss, these mechanisms are insufficient to restore long-term CD4<sup>+</sup> T-cell counts after thymectomy.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>By unifying diverse clinical and experimental observations within a multiscale mechanistic quantitative framework, the proposed model offers a robust tool for predicting CD4<sup>+</sup> T-cell dynamics and assessing the impact of physiological changes or interventions on immune homeostasis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>age-dependent homeostasis</kwd>
<kwd>CD4+ T-lymphocytes</kwd>
<kwd>mechanistic modeling</kwd>
<kwd>thymectomy</kwd>
<kwd>thymus involution</kwd>
<kwd>aging</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">
<institution-wrap>
<institution>Ministry of Education and Science of the Russian Federation</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100003443</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="sp1">075-15-2025-347</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">
<institution-wrap>
<institution>Russian Science Foundation</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100006769</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="sp2">23-71-10051</award-id>
</award-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Academic leadership program Priority 2030 proposed by the Federal State Autonomous Educational Institution of Higher Education, the Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) and Modeling &amp; Simulation Decisions FZ - LLC, Dubai, UAE. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication. GB was supported by the Moscow Center of Fundamental and Applied Mathematics at INM RAS (agreement with the Ministry of Education and Science of the Russian Federation No. 075-15-2025-347). V.K. and K.P. were supported by the Russian Science Foundation (Grant Number 23-71-10051).</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="86"/>
<page-count count="28"/>
<word-count count="17819"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Systems Immunology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>CD4<sup>+</sup> T-lymphocytes represent a key component of adaptive immunity, responsible for orchestrating and regulating human immune reactions. The mission of these cells extends beyond the assisting of cytotoxic CD8<sup>+</sup> T-lymphocytes and B-lymphocytes in their functions, activation of antigen-presenting cells, induction of early innate inflammatory responses, immune memory maintenance and other protecting functions (<xref ref-type="bibr" rid="B1">1</xref>). T-lymphocytes are widely targeted by newly developed immunotherapy medications, especially in Oncology applications. Genetically modified T-lymphocytes by chimeric antigen receptor (CAR) are used as immunotherapeutic agents in the treatment of hematological oncological diseases and solid tumors (<xref ref-type="bibr" rid="B2">2</xref>). Other types of immunotherapies, such as immune checkpoint inhibitors and the emerging T-cell engagers also interact with CD4<sup>+</sup> T-lymphocytes, by virtue of their targeting of malignant cells (<xref ref-type="bibr" rid="B3">3</xref>). Dysfunctions of these immune cells contribute to a potentially severe deterioration of human immunity. CD4<sup>+</sup> T-cells are the main targets of the human immunodeficiency virus (HIV); their depletion and exhaustion lead to acquired immunodeficiency syndrome (AIDS). Moreover, these cells are highly involved in autoimmune reactions (<xref ref-type="bibr" rid="B4">4</xref>). Homeostatic properties of CD4<sup>+</sup> T-lymphocytes, together with their regulation and quantification are of great interest to researchers in fundamental and clinical immunology, in their journey to both unravel unknown immune mechanisms and develop novel targeted pharmacological treatments and vaccines (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>T-cell development begins in the thymus gland and continues through peripheral maturation with sequential differentiation from recent thymic emigrants (RTE) to na&#xef;ve T-cells (<xref ref-type="bibr" rid="B6">6</xref>). The first encounter with a foreign antigen leads to the activation of specific na&#xef;ve cells coupled with clonal expansion and formation of both effector and memory phenotypes (<xref ref-type="bibr" rid="B7">7</xref>). Memory CD4<sup>+</sup> T-cells comprise a heterogeneous subpopulation of cells, including stem cell-like-, central-, effector-, and resident-memory subsets, and provide rapid and robust responses upon re-exposure to antigens (<xref ref-type="bibr" rid="B8">8</xref>). Cell migration relies on a differentiation stage of cell surface and expression of homing markers, i.e., CCR7<sup>+</sup> and CD62L<sup>+</sup> (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>Next to differentiation and transition aspects, another homeostatic property of CD4<sup>+</sup> T-lymphocytes and the immune system in general pertains to age-dependent alterations. Aging of the immune system is a complex and multifactorial physiological process that unfolds across various biological scales, from molecular signaling pathways to cellular populations and entire tissues. It encompasses a wide range of changes, including a gradual thymus involution reducing mature T-lymphocytes output, systemic inflammation and immunosenescence, revealing functional impairment of immune cells (<xref ref-type="bibr" rid="B10">10</xref>). These changes contribute to a progressive decline in immune system function, affecting its ability to eliminate infectious agents or malignant cells.</p>
<p>The investigation of immune T-cells homeostasis, their kinetics and distribution aspects as well as age-related changes continues to receive high attention from experimental and theoretical immunologists. A large variety of experimental <italic>in vitro</italic> and <italic>in vivo</italic> data, obtained by flow cytometry, BrdU of deuterium labeling methods, signal joint TCR excision circles (TRECs) content measurement and others, have been used to explore and quantify T-cell homeostasis (<xref ref-type="bibr" rid="B5">5</xref>). Computational modeling is one quantitative tool to describe kinetics of immune cells; among other features, it has provided well-established estimates of cellular turnover rates (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). However, in order to further sort through intricate mutual influences of immune cells in the context of homeostasis, it is necessary to consider aspects of cell differentiation and migration throughout the organism.</p>
<p>In the study of age-dependent homeostasis of T-lymphocytes, several questions related to the nature of compensatory mechanisms on the age-related decrease in thymic output, as well as mechanisms of T-cell memory longevity remain unresolved (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Most of the experimental research in the field is based on &#x201c;young&#x201d; vs. &#x201c;old&#x201d; group comparisons, which hampers the extrapolation of results across multiple age groups spanning the human lifespan (<xref ref-type="bibr" rid="B15">15</xref>). To derive further detailed insights on the mechanisms of age-related changes and the most critical determinants of T-cell homeostasis, a thorough curation of the available quantitative information on T-lymphocyte homeostasis, with respect to the characteristics of the performed experiments (particularly in terms of the age of the studied subjects) is required. There have been several attempts to evaluate the age dynamics of immune cell counts, based on large amounts of quantitative data (<xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>). In the recent work of Schr&#xf6;ter et&#xa0;al., age-related changes of lymphocyte concentrations were mathematically described, using a modified exponential decay function with a delay, based on an extensive dataset of specific data on various cell subpopulations (<xref ref-type="bibr" rid="B17">17</xref>). Schr&#xf6;ter and colleagues were among the first to quantitatively identify the age dynamics of cells, in the first years of human life. We recently performed a systematic review and meta-analysis, gathering all available quantitative information from multiple sources, on concentrations of multiple lymphocyte subpopulations in blood and peripheral organs (<xref ref-type="bibr" rid="B18">18</xref>). As a result, we obtained generalized estimates of cell concentrations across narrow age groups. While a further standalone description of distinct immune cell subpopulations may provide an accurate quantitative capture of cell homeostasis, it may not allow to decipher specific mechanisms of age-related changes and their regulation.</p>
<p>The primary objective of the present study was 1) to quantitatively characterize age-related homeostasis of CD4<sup>+</sup> T-lymphocyte subpopulations, by curating information and data on cellular kinetics and age-dependent dynamics and 2) to integrate these into a quantitative, physiologically-based mathematical model. The homeostatic model was developed with respect to the biology of differentiation, proliferation and migration of multiple subpopulations of CD4<sup>+</sup> T-lymphocytes. Combining multi-level data into a mechanistic model enabled the investigation of changes in cellular homeostasis in response to perturbations, to test the hypothesis on the mechanisms of age-related alterations in homeostasis and to determine which homeostatic processes are most influenced by age-related changes.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Data</title>
<sec id="s2_1_1">
<label>2.1.1</label>
<title>Clinical data on T-lymphocytes homeostasis</title>
<p>Clinical data on T-lymphocyte counts for several cell subpopulations spanning diverse age groups were required for homeostatic model development. Results from a previously performed systematic review and meta-analysis on age-dependent human T-lymphocyte homeostasis were used as a main source of quantitative data (<xref ref-type="bibr" rid="B18">18</xref>). The weighted averages as generalized estimates calculated within prespecified age intervals for each CD4<sup>+</sup> T-lymphocyte subpopulation in each organ were used for parameter estimation and model validation. Quantitative data on specific subpopulations of CD4<sup>+</sup> T-lymphocytes, such as RTE, na&#xef;ve, activated, central-memory, effector-memory and effector cells in blood, lymphoid tissue, the gastro-intestinal tract and lungs were used for calibration purposes, while the total subpopulations were used for model validation. Subsequent gating strategies and phenotypes of these cell subpopulations were fully described in the previous work (<xref ref-type="bibr" rid="B18">18</xref>). To evaluate the ability of the model to predict the overall immune status with age, model validation was performed against concentrations of total CD4<sup>+</sup> T-lymphocytes and of total memory (CD45RO<sup>+</sup>) CD4<sup>+</sup> T-lymphocytes in blood and lymphoid tissue.</p>
<p>In addition to cell concentration data, quantitative estimates on the total blood volume for different age groups and thymus wet weight were collected (<xref ref-type="bibr" rid="B19">19</xref>&#x2013;<xref ref-type="bibr" rid="B26">26</xref>). Total blood volume data were used for parameterization of its dependency with age, to obtain the model-predicted values on cell concentrations in blood (<xref ref-type="bibr" rid="B19">19</xref>&#x2013;<xref ref-type="bibr" rid="B24">24</xref>). An additional thymus wet weight data source (<xref ref-type="bibr" rid="B26">26</xref>), with data for the first years of life was exploited to inform the previously developed model of thymocytes homeostasis in healthy subjects (<xref ref-type="bibr" rid="B27">27</xref>). Since this sub-model was used as one of the mechanistic model building blocks, the data on thymus wet weight were used to parameterize the age dependency of wet weight (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). Moreover, to evaluate the model&#x2019;s ability to capture cell dynamics under cellular homeostasis perturbations, individual data from patients who underwent complete thymectomy in their childhood, from early infancy to 6 years of age, were additionally collected (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>Detailed information on the clinical data used in the analysis, including age group ranges and evaluation procedure, is presented in the <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;1</bold></xref>.</p>
</sec>
<sec id="s2_1_2">
<label>2.1.2</label>
<title>Experimental estimates of homeostatic processes</title>
<p>To obtain quantitative information on CD4<sup>+</sup> T-lymphocyte subpopulation kinetics, various sources of experimental <italic>in vitro</italic> and <italic>in vivo</italic> mouse data, as well as clinical data from deuterium labeled T-cell kinetic studies and modeling results were examined (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B30">30</xref>&#x2013;<xref ref-type="bibr" rid="B49">49</xref>). Death rates for CD4<sup>+</sup> T-lymphocyte subpopulations were calculated according to the half-life estimates obtained mostly from deuterium labeling kinetic data modeling (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B35">35</xref>&#x2013;<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Allometric scaling was used for the calculation of kinetic rates, from mouse data (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>). Transition rates of distinct T-lymphocytes across tissues were assessed following the Ganusov and Tomura analysis (<xref ref-type="bibr" rid="B48">48</xref>). Moreover, point estimates of mechanistic quantitative systems pharmacology (QSP) models were also used to obtain physiologically meaningful intervals for model parameters (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B42">42</xref>). The proposed ranges were used to inform initial parameter values for calibration. The values of experimental ranges, as well as a detailed description of the proposed assumptions are summarized in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Tables&#xa0;2</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>3</bold></xref>, respectively.</p>
</sec>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Modeling workflow</title>
<p>A sequential modeling approach was applied to formulate, calibrate and validate the model of CD4<sup>+</sup> T-lymphocytes age homeostasis. The proposed data-based workflow includes four stages (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>):</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Scheme for the model-based description and analysis of age-dependent CD4<sup>+</sup> T-lymphocyte homeostasis (stage 1 <bold>(A)</bold> &#x2013; model-based description of CD4<sup>+</sup> T-lymphocytes cellular kinetics in homeostasis following a multi-compartmental framework; stage 2 <bold>(B)</bold> &#x2013; parameterization of age-dependent changes in homeostasis; stage 3 <bold>(C)</bold> &#x2013; incorporation of intercellular regulation and its influence on age-dependent homeostasis; stage 4 <bold>(D)</bold> &#x2013; analysis and evaluation of the effect of various perturbations on cellular age-dependent homeostasis).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1742817-g001.tif">
<alt-text content-type="machine-generated">Diagram showing four stages of CD4+ T-lymphocyte cellular kinetics modeling: A) Reconstruction using infant data and thymus processes. B) Age-dependent homeostasis description with testing of age functions. C) Influence of cell counts on model parameters. D) Analysis of perturbations, thymectomy simulation, and sensitivity analysis across age groups, incorporating varied graphical elements and mathematical expressions.</alt-text>
</graphic></fig>
<list list-type="order">
<list-item>
<p>Model-based description of CD4<sup>+</sup> T-lymphocytes cellular kinetics in homeostasis following a multi-compartmental framework (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>)</p></list-item>
<list-item>
<p>Parameterization of age-dependent changes in homeostasis (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1B</bold></xref>)</p></list-item>
<list-item>
<p>Incorporation of intercellular regulation and its influence on age-dependent homeostasis (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1C</bold></xref>)</p></list-item>
<list-item>
<p>Analysis and evaluation of the effect of various perturbations on cellular age-dependent homeostasis (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1D</bold></xref>)</p></list-item>
</list>
<sec id="s2_2_1">
<label>2.2.1</label>
<title>Mathematical biology of CD4<sup>+</sup> T-lymphocytes cellular kinetics</title>
<sec id="s2_2_1_1">
<label>2.2.1.1</label>
<title>Model structure: multiple organs and cell compartments</title>
<p>To capture T-lymphocyte homeostasis and kinetics, several key aspects needed to be accounted for, such as T-lymphocyte maturation and development, circulation capacity, distinct subpopulation differentiation and expansion properties. The complete mechanistic homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics mathematical model was formulated with a system of 24 ordinary differential equations (ODEs), with 59 parameters presented in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>. The schematic structure of the mathematical model is shown in <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Scheme of the homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics model.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1742817-g002.tif">
<alt-text content-type="machine-generated">Flowchart showing the differentiation and movement of thymocytes and T-lymphocyte subpopulations through various body regions: thymus, lymphoid tissue, blood, gastrointestinal tract, and lungs. Labels include specific cell types such as DN, DP SP4 and SP8 thymocytes and RTE, na&#xef;ve, activated, effector, central- and effector-memory CD4+ T cells. Arrows represent processes like differentiation, proliferation, transfer, and death, with corresponding color-coded legend.</alt-text>
</graphic></fig>
<p>To account for T-lymphocyte maturation processes, we used our previously developed mechanistic model of thymocytes homeostasis as one of the building blocks of the cellular kinetics model (<xref ref-type="bibr" rid="B27">27</xref>). This model described the kinetics of the main thymocyte subpopulations &#x2013; double-negative (DN, CD4<sup>&#x2013;</sup>CD8<sup>&#x2013;</sup>), double-positive (DP, CD4<sup>+</sup>CD8<sup>+</sup>) and single-positive CD4<sup>+</sup> (SP4) and CD8<sup>+</sup> (SP8) cells (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 6</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>9</bold></xref>). Moreover, the model, by virtue of incorporating thymus involution (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 1</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>5</bold></xref>), captured age-related changes in thymocyte subpopulation counts as well as the number of egressed T-lymphocytes. As the thymus is the main source of mature T-cells, it was crucial to consider this physiological compartment within the cellular kinetics model.</p>
<p>Upon reaching the periphery, T-lymphocytes undergo further differentiation as a result of interactions with antigen-presentation and self-renewal mechanisms. We proposed six CD4<sup>+</sup> T-lymphocytes subpopulations to be included in the cellular kinetic model: recent thymic emigrants (RTE, <inline-formula>
<mml:math display="inline" id="im1"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, CD31<sup>+</sup> CD45RA<sup>+</sup>), na&#xef;ve (N, <inline-formula>
<mml:math display="inline" id="im2"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, CD45RA<sup>+</sup> CD45RO<sup>&#x2013;</sup> CCR7<sup>+</sup>/CD62L<sup>+</sup>), activated (A, <inline-formula>
<mml:math display="inline" id="im3"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, HLA-DR<sup>+</sup> CD38<sup>+</sup>), central-memory (CM, <inline-formula>
<mml:math display="inline" id="im4"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, CD45RA<sup>&#x2013;</sup> CD45RO<sup>+</sup> CCR7<sup>+</sup>/CD62L<sup>+</sup>), effector-memory (EM, <inline-formula>
<mml:math display="inline" id="im5"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, CD45RA<sup>&#x2013;</sup> CD45RO<sup>+</sup> CCR7<sup>&#x2013;</sup>/CD62L<sup>&#x2013;</sup>), and effector (EFF, <inline-formula>
<mml:math display="inline" id="im6"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, CD45RA<sup>+</sup> CD45RO<sup>&#x2013;</sup> CCR7<sup>&#x2013;</sup>/CD62L<sup>&#x2013;</sup>) cells (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 16</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>35</bold></xref>). CD4<sup>+</sup> T-lymphocytes enter the blood circulation as a distinct subpopulation of na&#xef;ve T-cells &#x2013; CD31<sup>+</sup> RTE T-cells (<inline-formula>
<mml:math display="inline" id="im7"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) which differentiate into mature na&#xef;ve cells (<inline-formula>
<mml:math display="inline" id="im8"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) in secondary lymphoid organs. Homeostatic proliferation of RTE cells (<inline-formula>
<mml:math display="inline" id="im9"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) was neglected in the model, due to evidence of a lower level of proliferation, as compared to na&#xef;ve cells (<inline-formula>
<mml:math display="inline" id="im10"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) (<xref ref-type="bibr" rid="B31">31</xref>). Upon specific antigen encounter, na&#xef;ve T-cells (<inline-formula>
<mml:math display="inline" id="im11"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) become activated and undergo clonal expansion, which prompted us to include a distinct subpopulation of activated T-cells (<inline-formula>
<mml:math display="inline" id="im12"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) in the model. The expansion of activated T-cells (<inline-formula>
<mml:math display="inline" id="im13"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) was described by a logistic growth equation, to limit excessive and non-physiological cell proliferation (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equation 22</bold></xref>). The subsequent differentiation of T-lymphocytes was described with respect to bifurcation theory, which favors a simultaneous formation of effector (<inline-formula>
<mml:math display="inline" id="im14"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) and memory (<inline-formula>
<mml:math display="inline" id="im15"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im16"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) T-cells (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>). The diversity of memory T-cell subsets was accounted for in the model, by including central-memory (<inline-formula>
<mml:math display="inline" id="im17"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) and effector-memory (<inline-formula>
<mml:math display="inline" id="im18"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) subpopulations with respect to their longevity and self-renewal mechanisms, as well as the progressive differentiation into effector cells (<inline-formula>
<mml:math display="inline" id="im19"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) upon antigen re-exposure. Effector T-helper cells (<inline-formula>
<mml:math display="inline" id="im20"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>), as a short-lived subpopulation with immediate immune response function, were described as a terminal non-proliferating subpopulation.</p>
<p>Beyond the thymus, four physiological compartments &#x2013; blood, lymphoid tissue, gastro-intestinal tract and lungs &#x2013; were included in the model, to describe T-lymphocyte trafficking. While T-lymphocyte differentiation originates in lymphoid tissue, subsequent distribution of cells throughout the body occurs in blood. Circulatory aspects of distinct T-lymphocyte subpopulations were considered in the model structure. T-lymphocyte subsets (<inline-formula>
<mml:math display="inline" id="im21"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im22"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) that express lymph-homing markers &#x2013; the adhesion molecule CD62L and the chemokine receptor CCR7 &#x2013; were described as subpopulations which can migrate to other organs and recirculate to lymphatic tissue (<xref ref-type="bibr" rid="B8">8</xref>). In contrast, for T-lymphocyte subsets (<inline-formula>
<mml:math display="inline" id="im23"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im24"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) that lack expression of CCR7 and CD62L, recirculation to lymphatic tissue was not included in the model. Moreover, for effector cells (<inline-formula>
<mml:math display="inline" id="im25"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>), emigration to an infection site only was considered.</p>
<p>Several assumptions were made to reduce the dimensionality of the model parameter space. Firstly, the death rate for each of the proposed T-lymphocyte subsets was assumed to be the same for each physiological compartment, except for blood, where the first-order disappearance rate represents not only cell apoptosis but also distribution to other organs. Secondly, the migration rates from blood to/from the gastro-intestinal tract and to/from the lungs were assumed to be the same within each T-cell subpopulation. This assumption is supported by the similar cell percentage in these organs during the first year of life (<xref ref-type="bibr" rid="B18">18</xref>). The validity of the proposed assumptions was tested in a sensitivity analysis.</p>
</sec>
<sec id="s2_2_1_2">
<label>2.2.1.2</label>
<title>Model calibration via data-driven parameterization</title>
<p>To calibrate CD4<sup>+</sup> T-lymphocyte cellular kinetics parameters, cell concentration data from the youngest age group for each cell subpopulation within each physiological compartment were applied. The youngest age group was chosen for calibration, to initially omit any age-related processes which may influence cellular homeostasis. The proposed dataset of 20 datapoints, which included weighted averages of cell concentrations (cells/&#x3bc;L for blood and % for other compartments) for the specific age interval were used as steady-state values for each model variable (<xref ref-type="bibr" rid="B18">18</xref>). The age of the &#x201c;youngest&#x201d; interval for each subpopulation was set to 0 and considered as a predictor variable (regressor) in the model, to calculate maximal cortex and medulla capacity in the thymocyte homeostasis sub-model, and to subsequently account for the extent of T-cells egressed from the thymus (<xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>Several structural model adaptations were made accordingly, during the model calibration phase. Firstly, as model variables represented numbers of cells in distinct compartments (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 16</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>35</bold></xref>), a calculation of cell concentrations was performed. For example, in lymphatic tissue, the gastro-intestinal tract and the lung compartments, percentages of cell subpopulations were calculated based on the sums of the model variable values within the compartments (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 50</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>63</bold></xref>). To convert numbers of cells in blood to measured cell concentrations (cells/&#x3bc;L) (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 36</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>41</bold></xref>), an age-dependent function of blood volume was used (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equation 15</bold></xref>). The parameterization of this dependency was based on a mathematical model of body weight vs age (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 10</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>14</bold></xref>) (<xref ref-type="bibr" rid="B54">54</xref>). The blood volume was scaled relative to body weight using individual and aggregated data on blood volume (see Section 2.1.1 and <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;1</bold></xref>), with the assumption that these physiological parameters feature the same dynamics across age groups. Secondly, as the cellular kinetics model was calibrated on data from the first years of life with respect to the observed increases in cell concentrations during early childhood (<xref ref-type="bibr" rid="B18">18</xref>), the thymus involution part of the previously developed thymocyte homeostasis sub-model required adaptation (<xref ref-type="bibr" rid="B27">27</xref>). To capture changes in thymus function during the first two years of age, thymus wet weight vs. age dependency (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equation 1</bold></xref>) was taken into account using additional data (see Section 2.1.1 and <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;1</bold></xref>).</p>
<p>As thymus involution and blood volume changes were the only age-dependent processes incorporated in the homeostatic cellular kinetics model, the ability of the developed model to describe age-related changes in cell concentrations was additionally evaluated.</p>
</sec>
</sec>
<sec id="s2_2_2">
<label>2.2.2</label>
<title>Description of age-dependent changes in homeostasis processes</title>
<p>To capture age-related changes in CD4<sup>+</sup> T-lymphocyte homeostasis, various functional forms of the parameter age dependency were evaluated. A sequential stepwise approach with forward selection and backward elimination was applied, to identify all relevant age dependencies and build the full age-dependent CD4<sup>+</sup> T-lymphocyte homeostasis model. The calibration dataset featured cell concentrations vs. age data for 20 model variables (see Section 2.1.1 and <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;1</bold></xref>), which were treated as steady-state values. Age was incorporated in the model as a regressor. Cellular kinetics model parameter values were fixed based on results from the homeostatic model developed in the previous step (see Section 2.2.1). In the forward selection step, four types of empirical functional age dependencies &#x2013; linear, exponential, hyperbolic and quadratic (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1B</bold></xref>) &#x2013; were tested sequentially, on each model parameter. As a result of the iterative forward selection step, the full model with all consistent age functions was built. In the backward elimination step, the selected age dependencies were sequentially removed from the full model, to test whether an age-dependent function would not significantly contribute to data description, once other age dependencies were included in the model. Model selection at each step was based on the identifiability of age-dependent parameters and lower Akaike information criterion (AIC) values. All selected age dependencies were also evaluated in terms of physiological relevance.</p>
</sec>
<sec id="s2_2_3">
<label>2.2.3</label>
<title>Quantitative assessment of CD4<sup>+</sup> T-lymphocyte homeostasis regulation</title>
<p>To better capture dynamical changes in CD4<sup>+</sup> T-lymphocyte kinetics and homeostasis in response to specific perturbations (e.g., thymectomy and/or acute infection), empirical age-dependent functions in the model were evaluated and replaced with more physiologically-justified mechanistic dependencies (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1C</bold></xref>). The hyperbolic dependencies of model parameters vs. cell counts and concentrations were explored and tested sequentially with respect to their physiological meaning. Parameters from non-replaced age dependencies from the previously developed model were estimated alongside with the tested functions. The final age-dependent CD4<sup>+</sup> T-lymphocyte homeostasis model was selected according to the identifiability of parameters and AIC comparisons vs. the model developed in the previous step (see Section 2.2.2).</p>
</sec>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Methodology of model development, performance evaluation and validation</title>
<p>Model development and evaluation were conducted according to the current standards of quantitative system pharmacology and physiologically-based mechanistic modeling (<xref ref-type="bibr" rid="B55">55</xref>&#x2013;<xref ref-type="bibr" rid="B59">59</xref>). A sequential modular approach was used, both to distinguish homeostatic and age-dependent processes of T-lymphocytes functioning and to reduce the parameter space per optimization procedure. Several parameter values were fixed based on prior knowledge on homeostasis processes (see 2.1.2 Section) (<xref ref-type="bibr" rid="B55">55</xref>&#x2013;<xref ref-type="bibr" rid="B59">59</xref>). For the fixed parameter values with non-informative priors, a likelihood function profiling was applied to obtain the best estimates of the model objective function and to evaluate uncertainty. A plausible uncertainty range (95% confidence interval) for each parameter was obtained via profile the likelihood method, by fixing the parameter across a grid of values, re-optimizing the remaining parameters, and retaining values that yielded near-minimal negative log-likelihood while demonstrating practical identifiability. A proportional residual error model was chosen for all model variables with fixed residual error parameter values, on the respective coefficients of variation (CV) of dependent variables, calculated using the calibration dataset. Identifiability of the estimated parameters was assessed via parameter relative standard error (RSE) values, where parameters with RSE greater than 51% were considered unidentifiable (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B59">59</xref>). Model comparison and selection on the 2<sup>nd</sup> and 3<sup>rd</sup> steps during age-dependent model development were based on identifiability analyses, as well as an AIC-based assessment of models; the model featuring the lowest AIC was then selected. To ensure the computed best-fit solution was at a non-improvable minimum, a multi-start parameter optimization procedure was applied, with 15 iterations.</p>
<p>The description of age-related changes in CD4<sup>+</sup> T-lymphocyte concentrations was assessed via simulations of steady-state values for each dependent variable, at a given age point. According to the sequential model development approach, model predictions accounted for uncertainty only in parameters calibrated at the respective modeling step. Uncertainty in CD4<sup>+</sup> T-lymphocyte homeostasis or age- or cell count-dependent parameters were included in model simulations, with 1000 sampled parameter sets for simulation. Predicted means with 95% confidence intervals (CIs) were plotted against the respective observed means and 95% CIs of the data. Visual model diagnostics were also performed, by comparing predicted values against observed data and by presenting weighted model residuals against predicted values and respective ages.</p>
<p>Model evaluation and analysis steps included a validation process of age-related changes in cell count representation, simulation of homeostasis perturbations (e.g., thymectomy), and a sensitivity analysis (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1D</bold></xref>). Along with the representation of age-related changes for specific cell subpopulations, the ability of the model to predict overall immune status with age was assessed using concentrations of total CD4<sup>+</sup> T-lymphocytes and total memory (CD45RO<sup>+</sup>) CD4<sup>+</sup> T-lymphocytes in blood and lymphoid tissue (<xref ref-type="bibr" rid="B18">18</xref>) as well as absolute counts of total CD4<sup>+</sup> T-lymphocytes in blood and peripheral organs (<xref ref-type="bibr" rid="B60">60</xref>). The accuracy of independent data description was assessed by comparing the observed and predicted 95% CIs for each total CD4<sup>+</sup> T-lymphocyte population. For each age group (0&#x2013;1 year of age; 1&#x2013;18 year of age; 18&#x2013;40 year of age; &gt;40 year of age), the percentage of datapoints for which the observed and predicted 95% CIs overlapped, or for which the difference between the CI limits did not exceed 30% of the observed values was calculated. Moreover, a full thymectomy condition was simulated, to assess the ability of the model to capture dynamics in T-lymphocyte homeostasis. To simulate such a condition, the number of SP4 thymocytes (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;4</bold></xref>,<xref ref-type="supplementary-material" rid="SM1"><bold>Equation 16</bold></xref>) was set to zero at the time of thymectomy and thereafter. For the dynamic simulation, initial values of the model variables were set to the subsequent steady-state values at the time of thymectomy, per each individual. If, for a given individual, data on T-cell counts prior to thymectomy were available, initial baseline values were corrected by the fraction of the difference between model-predicted cell count for a typical healthy subject and the observed data.</p>
<p>Sensitivity analyses were performed to quantify how a change in model parameter would impact homeostasis of CD4<sup>+</sup> T-lymphocytes. The partial rank correlation coefficient (PRCC) was used as a measure of global sensitivity (<xref ref-type="bibr" rid="B61">61</xref>). Global sensitivity analysis was performed for each dependent variable at select age points (0, 1, 20, 50, 80 years of age), representative of the chosen age groups. Three categories of parameters were used for sensitivity analysis: thymocyte homeostasis; CD4<sup>+</sup> T-lymphocyte homeostasis; and age- and cell count-dependent parameters (70 parameters in total). Thymocyte homeostasis parameters were sampled from physiologically plausible ranges, as defined in (<xref ref-type="bibr" rid="B27">27</xref>), whereas CD4<sup>+</sup> T-lymphocyte homeostasis and age- and cell count-dependent parameters were sampled from a uniform distribution with &#xb1; 25% value ranges, using a latin hypercube sampling method, to conduct the global sensitivity analysis (<xref ref-type="bibr" rid="B61">61</xref>). The sample size (i.e., the number of simulation runs) was set to 10,000; sensitivity analysis results were checked for consistency by increasing the sample size. Prior to PRCC calculation, the monotonic relationship between variables and parameter values was assessed. The influence of parameters for which PRCC was greater than or equal to 0.5 in absolute value was considered significant for the corresponding model outputs. To assess pairwise parameter interactions affecting the model-predicted number of CD4<sup>+</sup> T-lymphocytes, two-parameter iso-line contour plots were computed for selected parameter pairs at fixed ages. For each pair, parameters were sampled from a uniform distribution with &#xb1; 25% value ranges on a 2D grid while all remaining parameters were held at their nominal values, and iso-output contour plots were generated to visualize compensation and nonlinear interaction patterns.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Software</title>
<p>Model calibration was performed using the Monolix software (version 2020R1; Lixoft; <ext-link ext-link-type="uri" xlink:href="https://www.simulations-plus.com/software/monolix/monolix/">https://www.simulations-plus.com/software/monolix/monolix/</ext-link>). Model evaluation, validation and sensitivity analyses were performed in the R statistics software (version 4.2.3; packages: rxode2, sensitivity, tidyverse; <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">www.r-project.org</ext-link>). Data digitization was conducted in PlotDigitizer (<ext-link ext-link-type="uri" xlink:href="https://plotdigitizer.com/">https://plotdigitizer.com/</ext-link>). Model code is available in the <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Materials</bold></xref>.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Model-based description of homeostatic CD4<sup>+</sup> T-lymphocyte kinetics</title>
<p>The homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics model (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>) calibration results are presented in <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>. A total of 26 parameter values were fixed, and 19 parameters were estimated using meta-analytical generalized estimates on cell concentration data for the first years of life. Age as a regressor in the model was fixed to 0, influencing the age-related changes in thymic function (<inline-formula>
<mml:math display="inline" id="im26"><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im27"><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and blood volume (<inline-formula>
<mml:math display="inline" id="im28"><mml:mrow><mml:mi>B</mml:mi><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>), which captures cell homeostasis for newborns. Each one of the estimated parameters was assessed as identifiable (RSE&lt; 51%) (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>). For the fixed parameters, values were obtained either from derived physiological experimental estimates (see <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;2</bold></xref> for subsequent derivations) or based on sensitivity and likelihood profiling analyses.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics model calibration results.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Parameter, units</th>
<th valign="middle" align="left">Description</th>
<th valign="middle" align="left">Parameter Value</th>
<th valign="middle" align="left">RSE, %</th>
<th valign="middle" align="left">Source *</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im29"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Death rate of RTE CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.0076</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im30"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>_</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of RTE CD4<sup>+</sup> T-cells from blood to lymphatic tissue</td>
<td valign="middle" align="left">0.217</td>
<td valign="middle" align="left">6.21</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im31"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Differentiation rate of RTE to na&#xef;ve CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.0012</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B32">32</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im32"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Death rate of na&#xef;ve CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.000457</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im33"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Proliferation rate of na&#xef;ve CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.0007</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B40">40</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im34"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Differentiation rate of na&#xef;ve to activated CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.0012</td>
<td valign="middle" align="left">1.01</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im35"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of na&#xef;ve CD4<sup>+</sup> T-cells from lymphatic tissue to blood</td>
<td valign="middle" align="left">1.64</td>
<td valign="middle" align="left">6.13</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im36"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of na&#xef;ve CD4<sup>+</sup> T-cells from blood to lymphatic tissue</td>
<td valign="middle" align="left">40</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B43">43</xref>&#x2013;<xref ref-type="bibr" rid="B45">45</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im37"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im38"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im39"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im40"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of na&#xef;ve CD4<sup>+</sup> T-cells from blood to gastro-intestinal tract/lungs/other peripheral tissues and activated CD4<sup>+</sup> T-cells from blood to peripheral tissues</td>
<td valign="middle" align="left">0.0003</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on sensitivity and likelihood profiling analysis</italic></td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im41"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im42"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of na&#xef;ve CD4<sup>+</sup> T-cells from the gastro-intestinal tract/lungs to blood</td>
<td valign="middle" align="left">0.00075</td>
<td valign="middle" align="left">18.63</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im43"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Proliferation rate of activated CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">1.725</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B85">85</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im44"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Differentiation rate of activated CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">1.727</td>
<td valign="middle" align="left">0.12</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im45"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Death rate of activated CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.04</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im46"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of activated CD4<sup>+</sup> T-cells from lymphatic tissue to blood</td>
<td valign="middle" align="left">4.06</td>
<td valign="middle" align="left">10.17</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im47"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of activated CD4<sup>+</sup> T-cells from blood to lymphatic tissue</td>
<td valign="middle" align="left">40</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B43">43</xref>&#x2013;<xref ref-type="bibr" rid="B45">45</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im48"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, -</td>
<td valign="middle" align="left">Fraction of activated CD4<sup>+</sup> T-cells, differentiated to central-memory CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.4</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B15">15</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im49"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, cells</td>
<td valign="middle" align="left">Maximal carrying capacity of activated CD4<sup>+</sup> T-cells proliferation</td>
<td valign="middle" align="left">10<sup>13</sup></td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B85">85</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im50"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Proliferation rate of central-memory CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.0391</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B40">40</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im51"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Death rate of central-memory CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.041</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B42">42</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im52"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Differentiation rate of central-memory to effector-memory CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.111</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B38">38</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im53"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of central-memory CD4<sup>+</sup> T-cells from lymphatic tissue to blood</td>
<td valign="middle" align="left">0.334</td>
<td valign="middle" align="left">9.39</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im54"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of central-memory CD4<sup>+</sup> T-cells from blood to lymphatic tissue</td>
<td valign="middle" align="left">10</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im55"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im56"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im57"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of central-memory CD4<sup>+</sup> T-cells from blood to the gastro-intestinal tract/lungs/other peripheral tissues</td>
<td valign="middle" align="left">0.12</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on sensitivity and likelihood profiling analysis</italic></td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im58"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im59"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of central-memory CD4<sup>+</sup> T-cells from the gastro-intestinal tract to blood</td>
<td valign="middle" align="left">0.09</td>
<td valign="middle" align="left">19.44</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im60"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Proliferation rate of effector-memory CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.042</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B40">40</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im61"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Death rate of effector-memory CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.11</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B42">42</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im62"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Differentiation rate of effector-memory to effector CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.035</td>
<td valign="middle" align="left">33.02</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im63"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of effector-memory CD4<sup>+</sup> T-cells from lymphatic tissue to blood</td>
<td valign="middle" align="left">0.035</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im64"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im65"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im66"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of effector-memory CD4<sup>+</sup> T-cells from blood to the gastro-intestinal tract/lungs/other peripheral tissues</td>
<td valign="middle" align="left">0.882</td>
<td valign="middle" align="left">11.95</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im67"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im68"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of effector-memory CD4<sup>+</sup> T-cells from the gastro-intestinal tract/lungs to blood</td>
<td valign="middle" align="left">0.04</td>
<td valign="middle" align="left"/>
<td valign="middle" align="left"><italic>Fixed based on physiological range</italic><break/><italic>(</italic><xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B86">86</xref>)</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im69"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Death rate of effector CD4<sup>+</sup> T-cells</td>
<td valign="middle" align="left">0.87</td>
<td valign="middle" align="left">12.16</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im70"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of effector CD4<sup>+</sup> T-cells from lymphatic tissue to blood</td>
<td valign="middle" align="left">0.253</td>
<td valign="middle" align="left">23.05</td>
<td valign="middle" align="left">Estimated</td>
</tr>
<tr>
<td valign="middle" align="center"><inline-formula>
<mml:math display="inline" id="im71"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup><break/><inline-formula>
<mml:math display="inline" id="im72"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-</sup><break/><inline-formula>
<mml:math display="inline" id="im73"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, d<sup>-1</sup></td>
<td valign="middle" align="left">Transition rate of effector CD4<sup>+</sup> T-cells from blood to the gastro-intestinal tract/lungs/other peripheral tissues</td>
<td valign="middle" align="left">0.087</td>
<td valign="middle" align="left">23.32</td>
<td valign="middle" align="left">Estimated</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>* For fixed parameters see <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;2</bold></xref> for the respective physiological range</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The observed and predicted steady-state mean values with respective CIs are presented in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;1</bold></xref>. Since cell concentration data from the youngest age group were used for calibration purposes, the corresponding age range varied from the [0; 0.25] years for na&#xef;ve, central-memory and effector-memory cell blood concentrations, to [30; 50] years for the percentage of activated cells in lymphoid tissue. The age ranges used for model calibration are also depicted in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;1</bold></xref>. The model adequately described the data for nearly all CD4<sup>+</sup> T-lymphocyte subpopulations, despite its limited ability to capture the % of activated cells in lymphoid tissue. Since data were only available for the [30; 50] age group for this variable, and while the model was considered to reflect cellular homeostasis for newborns and the first years of life, the overall results of the model were considered reliable. Model parameters for the thymus wet weight and blood volume age dependencies calibrated separately are presented in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;5</bold></xref>. To validate model results, concentrations of total T-lymphocyte subsets were simulated. The predicted means with 95% CIs of total CD4<sup>+</sup> and total memory CD4<sup>+</sup> CD45RO<sup>+</sup> T-lymphocyte blood cell concentration were 2402 [2176; 2651] and 300 [263; 334] cells/&#x3bc;L, respectively. These values map well to the observed values for the 0-0.25 age group: 2215.23 [2023.43; 2407.03] and 393.33 [316.85; 469.82] cells/&#x3bc;L, respectively.</p>
<p>The model description of age-related dynamics is presented in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;2</bold></xref>. Model diagnostic plots are shown in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;3</bold></xref>. In general, the model was not able to fully capture long-term age-related changes in CD4<sup>+</sup> T-lymphocyte concentrations. Blood concentrations of less differentiated cell subsets (RTE, na&#xef;ve, activated T-cells) and effector cells decline with age - which is adequately captured in the homeostatic cellular kinetics model (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;2A</bold></xref>). Nevertheless, the model does not reproduce age-related changes for memory subsets (central-memory and effector-memory) since, for these subpopulations, blood concentrations do not decrease with age (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;2A</bold></xref>). Steady-state cell percentages in organs do not change over age, as no age-dependent variations in cellular kinetic processes were incorporated in the model (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;2B&#x2013;D</bold></xref>). However, the developed cellular kinetics model described the increase in blood cell concentrations for the first year of life (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;2A</bold></xref>). Since the model included age dependencies only at the level of the thymus and blood volume, it can be stated that the initial increase in T-lymphocytes and their expansion are primarily due to thymus production.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Accounting for the influence of age on CD4<sup>+</sup> T-lymphocyte homeostasis</title>
<p>Age-dependent changes in CD4<sup>+</sup> T-lymphocyte homeostasis processes were described via 13 empirical age-functions (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1B</bold></xref>). Na&#xef;ve (<inline-formula>
<mml:math display="inline" id="im74"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and activated (<inline-formula>
<mml:math display="inline" id="im75"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) T-cell proliferation rate, effector-memory T-cell transfer from lungs to blood (<inline-formula>
<mml:math display="inline" id="im76"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>), and effector cell transfer from blood to peripheral organs (<inline-formula>
<mml:math display="inline" id="im77"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im78"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im79"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) were found to increase with age. RTE T-cell death rate (<inline-formula>
<mml:math display="inline" id="im80"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and transfer rate from blood to lymphoid tissue (<inline-formula>
<mml:math display="inline" id="im81"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>), differentiation rates of central-memory to effector-memory (<inline-formula>
<mml:math display="inline" id="im82"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and effector-memory to effector (<inline-formula>
<mml:math display="inline" id="im83"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) T-cells, and transfer rates from lymphoid tissues to blood of activated (<inline-formula>
<mml:math display="inline" id="im84"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>), central-memory (<inline-formula>
<mml:math display="inline" id="im85"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and effector (<inline-formula>
<mml:math display="inline" id="im86"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) T-cells exhibited decreasing patterns with age. Hyperbolic functions were found to be the most adequate way to capture age-related changes. The schematic structure of the mathematical model with highlighted age-dependent processes is shown in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;4</bold></xref>.</p>
<p>The respective formulations and parameter estimates are presented in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Tables&#xa0;6</bold></xref> and <xref ref-type="supplementary-material" rid="SM1"><bold>7</bold></xref>, respectively. Overall, 15 and 8 parameter values were estimated and fixed, respectively, during the model calibration process. In the corresponding hyperbolic functions, the Hill coefficients for na&#xef;ve CD4<sup>+</sup> T-cell proliferation rate (<inline-formula>
<mml:math display="inline" id="im87"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and central-memory CD4<sup>+</sup> T-cell differentiation rate (<inline-formula>
<mml:math display="inline" id="im88"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) age dependencies were fixed to 10 and 3, respectively, to describe the shift in age-related changes in these processes (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;7</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 2</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>5</bold></xref> in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;6</bold></xref>). For decreasing age-functions, such as <inline-formula>
<mml:math display="inline" id="im89"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im90"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im91"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im92"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im93"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im94"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (<xref ref-type="supplementary-material" rid="SM1"><bold>Equations 4</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>6</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>11</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>13</bold></xref> in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;6</bold></xref>, respectively), parameter values representing the maximal relative decreases in the respective homeostatic processes were set to 1 (100% decrease), to reduce the dimensionality of the model parameter space. The validity of the proposed assumption was tested by sensitivity analysis, assessing the impact of variation in fixed parameter values on model outputs. Age-related changes of the effector T-cell migration rate were assumed to have the same dynamics across different organs (<inline-formula>
<mml:math display="inline" id="im95"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im96"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im97"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>; <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 8</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>10</bold></xref> in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;6</bold></xref>). Also, it was assumed that age-related changes in the homeostasis of effector-memory (<inline-formula>
<mml:math display="inline" id="im98"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im99"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and effector (<inline-formula>
<mml:math display="inline" id="im100"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im101"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im102"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) T-cells begin around the same age, which is reflected by fitting one parameter corresponding to an age of 50% increase in these processes (<inline-formula>
<mml:math display="inline" id="im103"><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>; <xref ref-type="supplementary-material" rid="SM1"><bold>Equations 6</bold></xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1"><bold>10</bold></xref> in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;6</bold></xref>). An evaluation of separate parameters for these dependencies led to non-identifiability issues for these parameters, due to a larger parameter space. A graphical representation of each age function can be found in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5</bold></xref>. The model selection process for the backward elimination step is captured in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;8</bold></xref>.</p>
<p>A description of age-related dynamics, based on the age-dependent CD4<sup>+</sup> T-lymphocyte homeostasis model is presented in <xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>. The complex nature of changes in cell concentrations in blood and organs with age were well captured, as compared to the homeostatic cellular kinetics model without the incorporation of such age effects, indicating the necessity of the proposed age functions. Diagnostic plots presented in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;6</bold></xref> also indicated an accurate age dynamics description, with a good correspondence between observed and predicted values.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Description of age-related cell dynamics, based on the homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics model with age effects included: Blood <bold>(A)</bold>, Lymphoid tissue <bold>(B)</bold>, Gastro-intestinal tract <bold>(C)</bold>, and Lungs <bold>(D)</bold>. Red dots represent observed data as meta-analytical weighted averages with 95% CIs; blue solid lines with shaded area represent predicted means with 95% CIs; purple shaded areas represent data description for neonates, infants and toddlers (0 to 5 years of age). For improved visualization, the percentage of effector cells is presented for the 0-10% range only, while the 0-100% range is shown for other cell subpopulations.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1742817-g003.tif">
<alt-text content-type="machine-generated">Graphs showing cell concentration trends by age across different tissues. Section A (Blood) includes RTE, Naive, Activated, Central-memory, Effector-memory, and Effector cells. Sections B (Lymphoid tissue), C (Gastro-intestinal tract), and D (Lungs) depict Naive, Central-memory, Efector-memory, and Effector cells. Red dots represent observed data, blue lines indicate model predictions with confidence intervals. Insets highlight early age data.</alt-text>
</graphic></fig>
<p>Each of the proposed age functions carries a plausible, biological explanation. The increase in activated T-cell proliferation <inline-formula>
<mml:math display="inline" id="im104"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5A</bold></xref>) features a saturation process, indicative of the evolution of clonal expansion in response to antigen stimulation in adulthood and its maintenance for the rest of human life. Homeostasis was most sensitive to the presence of this age dependence, according to the difference in likelihood values for the data described by model, with and without the <inline-formula>
<mml:math display="inline" id="im105"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> function (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;8</bold></xref>). The increase in clonal expansion efficiency was essential to ensure a sufficient supply of memory cells, with their subsequent accumulation throughout human life (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>; central-memory and effector-memory cells). For na&#xef;ve T-cells, the observed change in the proliferation rate <inline-formula>
<mml:math display="inline" id="im106"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5B</bold></xref>) ~50 years of age was consistent with the adaptation of na&#xef;ve T-cells to a decreased thymic output. The same reasoning may apply to explain the increase in the survival rate of RTE cells, <inline-formula>
<mml:math display="inline" id="im107"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5C</bold></xref>).</p>
<p>It is known that age-related changes from lesser to more differentiated T-lymphocytes are observed (<xref ref-type="bibr" rid="B10">10</xref>), which is consistent with cell concentrations simulated in both blood and other organs (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>) (<xref ref-type="bibr" rid="B18">18</xref>). One possible mechanism for this phenomenon may relate to age-dependent changes of differentiation rates of memory cells, which would correspond to immune response activation upon antigen re-exposure (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;5E, F</bold></xref>). Since the developed model included distinct subpopulations of human memory T-cells (i.e., central-memory and effector-memory), it enabled the examination of heterogeneity in age-related changes across memory subsets. Differences in age dynamics were found among memory cell subpopulations: the percentage of effector-memory T-cells in lymphoid tissue tended to decrease after 40 years of life, while the dynamics of central-memory T-cells exhibited the opposite pattern (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3B</bold></xref>). The same differences were observed for cell percentages in the gastro-intestinal tract and lungs (<xref ref-type="fig" rid="f3"><bold>Figures&#xa0;3C, D</bold></xref>). Such dynamics can be explained and described by an age-related decrease in the differentiation rate of central-memory to effector-memory cells <inline-formula>
<mml:math display="inline" id="im108"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5E</bold></xref>), which may lead to an accumulation of the former and a decline of the latter. A decrease in further differentiation from effector-memory to effector CD4<sup>+</sup> T-cells (<inline-formula>
<mml:math display="inline" id="im109"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) was also observed (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5F</bold></xref>), indicative of age-related changes in the immune system ability to respond to a secondary antigen exposure.</p>
<p>Age-related changes were also found with respect to transition rates between organs. Since the transfer rates to and from the gastro-intestinal tract were assumed to be equal to the respective rates for lungs (cell percentages for each of the cell subpopulations were comparable in newborns between these organs), a different age-related cell dynamics pattern was observed for the effector-memory subset. In particular, the decrease in the percentage of effector-memory T-cells, which was observed in the gastro-intestinal tract, was not observed in the lungs (<xref ref-type="fig" rid="f3"><bold>Figures&#xa0;3C, D</bold></xref>). Hence, an increasing saturation function for the transfer rate from lungs to blood, <inline-formula>
<mml:math display="inline" id="im110"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5G</bold></xref>), was proposed for effector-memory cells, to describe this difference. An opposing age function was introduced for activated, central-memory and effector T-cell transfer rates, from lymphoid tissue to blood (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;5I-K</bold></xref>). The transition of effector cells to peripheral tissues, as terminal action sites, were also described by increasing saturation functions with age (<inline-formula>
<mml:math display="inline" id="im111"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mo>&#xa0;</mml:mo><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mo>&#xa0;</mml:mo><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5H</bold></xref>). These dependencies delineated a gradual increase in the rate of dissemination of effector cells and the time of onset of the immune response up to adulthood (0&#x2013;20 years), in connection with the development of organ systems. Incorporation in the model of a decreasing age function for the RTE T-cell transfer rate from blood to lymphoid organs, <inline-formula>
<mml:math display="inline" id="im112"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5D</bold></xref>), enabled a better description of cell concentrations in blood. Since there was no proliferation of RTE cells included in the model structure, this age-dependent process captured not only age-related changes in peripheral transitions of RTE cells, but also the increase in proliferative activity of these cells and in export rates from the thymus, due to thymic involution compensation.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Incorporation of an intercellular regulation on age-dependent CD4<sup>+</sup> T-lymphocyte homeostasis</title>
<p>Empirical, age-dependent functions for homeostatic processes enabled an accurate description of the age-dependent homeostasis of CD4<sup>+</sup> T-lymphocytes. To evaluate a reciprocal cell influence on such homeostasis, age-dependent functions were tested by replacing them with negative or positive feedback functions, depending on T-cell concentrations or cell counts (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1C</bold></xref>). This exploratory analysis on potential cell count impact was performed by plotting the homeostatic process vs. cells counts or concentrations of precursor cells, using the homeostatic model with the age effect being incorporated, as described in the previous step (see Section 3.2). This analysis revealed that two age-dependent homeostatic processes, namely the na&#xef;ve CD4<sup>+</sup> T-cell proliferation rate and the RTE CD4<sup>+</sup> T-cell death rate (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;7A, C</bold></xref>; blue curves), depended on the concentration of RTE CD4<sup>+</sup> cells in blood (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;7B, D</bold></xref>; blue curves). The age-increasing proliferation rate of na&#xef;ve CD4<sup>+</sup> T cells tended to decrease with CD4<sup>+</sup> T cell RTE concentrations (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;7B</bold></xref>). Conversely, the RTE CD4<sup>+</sup> T-cell death rate increased with increasing RTE CD4<sup>+</sup> T cell concentrations, while the relationship with age showed the opposite trend (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;7D</bold></xref>). These dependencies could be explained by the immune system adapting to diminishing RTE or na&#xef;ve cell numbers, which can occur not only during thymic involution, but also under intervention and/or patho-physiological conditions such as thymectomy, thymomas, HIV infection and other conditions influencing the number of antigen-unexposed cells.</p>
<p>For the model to capture these homeostatic relationships, age-dependent functions were tested by replacing them with cell concentration-dependent functions. Upon iterative function replacements and model building, the final model included two RTE CD4<sup>+</sup> T-cell concentration-dependent hyperbolic functions &#x2013; for the na&#xef;ve CD4<sup>+</sup> T-cell proliferation rate (<inline-formula>
<mml:math display="inline" id="im113"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and the RTE CD4<sup>+</sup> T-cell death rate (<inline-formula>
<mml:math display="inline" id="im114"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) &#x2013; instead of the <inline-formula>
<mml:math display="inline" id="im115"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im116"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> functions, respectively. Other age-dependent functions incorporated in the model structure per the previous step (see Section 3.2) remained unchanged. The scheme of the mathematical model with the relevant age and cell count dependencies is shown in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;8</bold></xref>. The proposed equations are presented in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;9</bold></xref>. The baseline values of homeostatic processes for each of the hyperbolic functions (<inline-formula>
<mml:math display="inline" id="im117"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>B</mml:mi><mml:mi>A</mml:mi><mml:mi>S</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>&#xa0;</mml:mo><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im118"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>B</mml:mi><mml:mi>A</mml:mi><mml:mi>S</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>&#xa0;</mml:mo><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) were formulated according to the previously calibrated parameter values of <inline-formula>
<mml:math display="inline" id="im119"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im120"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>. Parameter estimate results are shown in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;10</bold></xref>. All parameter values for both the cell count-dependent (<inline-formula>
<mml:math display="inline" id="im121"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im122"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and age-dependent functions (<inline-formula>
<mml:math display="inline" id="im123"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im124"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im125"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im126"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im127"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im128"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im129"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im130"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im131"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im132"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im133"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) were identified. According to the exploratory analysis, the Hill coefficients <inline-formula>
<mml:math display="inline" id="im134"><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im135"><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> for <inline-formula>
<mml:math display="inline" id="im136"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im137"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, respectively, were set to 10, in order to describe the sharp shift in the nature of these homeostatic relationships.</p>
<p>A description of cell concentration dynamics with age, as performed by the homeostatic model following the inclusion of these cell influence functions is presented in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;9</bold></xref>. Model diagnostics are shown in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;10</bold></xref>. The proposed model accurately captured the age dynamics of CD4<sup>+</sup> T-lymphocytes, along with the age-dependent homeostatic model developed in the previous step (see Section 3.2). Also, the proposed model exhibits relationships of <inline-formula>
<mml:math display="inline" id="im138"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im139"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> with age (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;7A, C</bold></xref>; red curves) and with RTE concentration age (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;7B, D</bold></xref>; red curves) that are similar to the corresponding relationships in the age-dependent homeostatic model (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;7</bold></xref>; blue curves). The AIC values for the cell count-dependent and age-dependent models were, respectively, 4753.23 and 4862.35, indicative of an improved description of the observed data upon including these reciprocal cell influence functions in the model.</p>
<p>The overall performance of the homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetic model at each stage of development in reproducing observed CD4<sup>+</sup> T-lymphocyte subpopulation dynamics is presented in <xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Model performance summary across CD4<sup>+</sup> T-lymphocyte subpopulation age-dependent dynamics.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="center"/>
<th valign="top" rowspan="2" align="center">Model description</th>
<th valign="top" rowspan="2" align="center">Organ</th>
<th valign="top" rowspan="2" align="center">Age range</th>
<th valign="top" colspan="6" align="center">CD4<sup>+</sup> T-lymphocyte subpopulation</th>
<th valign="top" rowspan="2" align="center">Model insights</th>
</tr>
<tr>
<th valign="top" align="center">RTE</th>
<th valign="top" align="center">Na&#xef;ve</th>
<th valign="top" align="center">Activated</th>
<th valign="top" align="center">Central-memory</th>
<th valign="top" align="center">Effector-memory</th>
<th valign="top" align="center">Effector</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="30" align="center"><bold>Homeostatic&#xa0;CD4<sup>+</sup>&#xa0;T-lymphocyte&#xa0;cellular&#xa0;kinetics&#xa0;model</bold></td>
<td valign="top" rowspan="10" align="center">(1)<break/>without age effect on cellular kinetics</td>
<td valign="top" rowspan="4" align="left">Blood (cells/&#x3bc;L)</td>
<td valign="top" align="left">0&#x2013;1 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" rowspan="10" align="left">Initial expansion and subsequent decline of blood cell concentration are captured mainly through the age-dependent thymic involution component;<break/>Memory T-cell accumulation is not reproduced; na&#xef;ve/activated input is insufficient for homeostasis maintenance;<break/>No age-related changes in cell percentages are captured, as no age-dependent variations in cellular kinetic processes were incorporated into the model.</td>
</tr>
<tr>
<td valign="top" align="left">1&#x2013;18 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+/&#x2013;</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;40 y. of age</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" align="left">&gt;40 y. of age</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">+/&#x2013;</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Lymphoid tissue (%)</td>
<td valign="top" align="left">0&#x2013;18 y. of age</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;60 y. of age</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">+</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Gastro-intestinal tract (%)</td>
<td valign="top" align="left">0&#x2013;18 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;60 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+/&#x2013;</td>
<td valign="top" align="left">+</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Lungs (%)</td>
<td valign="top" align="left">0&#x2013;18 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;60 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" rowspan="10" align="center">(2)<break/>with age effect</td>
<td valign="top" rowspan="4" align="left">Blood (cells/&#x3bc;L)</td>
<td valign="top" align="left">0&#x2013;1 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" rowspan="10" align="left">An age-shifted increase in na&#xef;ve T-cell proliferation rate (<inline-formula>
<mml:math display="inline" id="im140"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) reproduces the slight rise in blood concentration at ~64 years as an adaptation to decreased thymic output;<break/>The accumulation of memory T-cells is achieved through an increase and maintenance of a higher activated T-cell proliferation rate (<inline-formula>
<mml:math display="inline" id="im141"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) compared to newborns;<break/>Central-memory concentration peak at ~64 years and effector-memory percentage decline after ~40 years is captured by a decrease in the differentiation rate of central-memory to effector-memory cells (<inline-formula>
<mml:math display="inline" id="im142"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>).</td>
</tr>
<tr>
<td valign="top" align="left">1&#x2013;18 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;40 y. of age</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" align="left">&gt;40 y. of age</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+/&#x2013;</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Lymphoid tissue (%)</td>
<td valign="top" align="left">0&#x2013;18 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;60 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+/&#x2013;</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Gastro-intestinal tract (%)</td>
<td valign="top" align="left">0&#x2013;18 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;60 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+/&#x2013;</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Lungs (%)</td>
<td valign="top" align="left">0&#x2013;18 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;60 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" rowspan="10" align="center">(3)<break/>with age and cellular feedback effects</td>
<td valign="top" rowspan="4" align="left">Blood (cells/&#x3bc;L)</td>
<td valign="top" align="left">0&#x2013;1 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" rowspan="10" align="left">An increase in na&#xef;ve T-cell proliferation rate depending on RTE cells concentration (<inline-formula>
<mml:math display="inline" id="im143"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) reproduces the rise at ~64 years as an adaptation to decreased thymic output.</td>
</tr>
<tr>
<td valign="top" align="left">1&#x2013;18 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;40 y. of age</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" align="left">&gt;40 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+/&#x2013;</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Lymphoid tissue (%)</td>
<td valign="top" align="left">0&#x2013;18 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;60 y. of age</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+/&#x2013;</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Gastro-intestinal tract (%)</td>
<td valign="top" align="left">0&#x2013;18 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;60 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Lungs (%)</td>
<td valign="top" align="left">0&#x2013;18 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" align="left">18&#x2013;60 y. of age</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">n/a</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Cell phenotypes: RTE: CD45RA<sup>+</sup>CD31<sup>+</sup>; Na&#xef;ve: CD45RA<sup>+</sup>CD45RO<sup>&#x2013;</sup>CCR7<sup>+</sup>/CD62L<sup>+</sup>; Activated: CD38<sup>+</sup>HLADR<sup>+</sup>; Central-memory: CD45RA-CD45RO<sup>+</sup>CCR7<sup>+</sup>/CD62L<sup>+</sup>; Effector-memory: CD45RA<sup>&#x2013;</sup>CD45RO<sup>+</sup>CCR7<sup>&#x2013;</sup>/CD62L<sup>&#x2013;</sup>; Effector: CD45RA<sup>+</sup>CD45RO<sup>&#x2013;</sup>CCR7<sup>&#x2013;</sup>/CD62L<sup>&#x2013;</sup>; y. - years; n/a - not applicable;</p></fn>
<fn>
<p>+++ &#x2014; complete overlap between observed and predicted 95% CIs (100% of cases); ++ &#x2014; overlap between observed and predicted 95% CIs in &gt;75% of cases or the absolute difference between observed and predicted 95% CI limits &#x2264;30% of the observed value (100% of cases); + &#x2014; overlap between observed and predicted 95% confidence intervals in &gt;50% of cases or the difference between observed and predicted 95% CI limits &#x2264;30% of the observed value in &gt;50% of cases; +/&#x2013; &#x2014; overlap between observed and predicted 95% CIs in &gt;20% of cases or the difference between observed and predicted 95% CI limits &#x2264;30% of the observed value in &gt;20% of cases; &#x2013; &#x2014; overlap between observed and predicted 95% CIs in&lt;20% of cases and the difference between observed and predicted 95% CI limits &#x2264;30% of the observed value in&lt;20% of cases within the selected age range.</p></fn>
<fn>
<p>Age-related cell dynamic representation results are presented in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;2</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>Figure&#xa0;2</bold></xref> and <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;9</bold></xref> for homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics model (1) (without age effect on cellular kinetics), (2) (with age effect) and (3) (with age and cellular feedback effects), respectively.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Model evaluation and analysis</title>
<sec id="s3_4_1">
<label>3.4.1</label>
<title>Model validation on external data</title>
<p>A model evaluation analysis was conducted, to test the hypotheses underlying the model structure and to assess the generalizability of the system (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1D</bold></xref>). An independent dataset of total CD4<sup>+</sup> and total memory CD4<sup>+</sup> CD45RO<sup>+</sup> T-lymphocyte concentrations was used to evaluate the model ability to describe the overall immune homeostasis (<xref ref-type="bibr" rid="B18">18</xref>). Model validation results per each model development step are presented in <xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>, <xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref>. With respect to specific CD4<sup>+</sup> T-cell subpopulations (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;2</bold></xref>), age-related changes in total CD4<sup>+</sup> T-lymphocytes were not described by the basic cellular kinetics model (observed and predicted CIs overlapped in 12.9% of cases; <xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4A</bold></xref>, <xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref>). Nevertheless, the observed increase in blood concentrations in the first years of life was well captured by the model, indicating the pivotal role of thymic output in the overall immune system functioning in early childhood. Incorporation of age-dependent and cell-dependent functions drastically improved the description of the data (observed and predicted CIs overlapped in 45.2% of cases; <xref ref-type="fig" rid="f4"><bold>Figures&#xa0;4B, C</bold></xref>, <xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref>). Inclusion of cellular feedback influences yielded more precise total memory cell blood concentration predictions for the 50&#x2013;70 years-of-age group (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4C</bold></xref>), in instances where an increase in memory cells was observed, as compared to the model with inclusion of age effects only (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4B</bold></xref>) (percentage differences between observed and predicted mean values were 22.3% and 21.9% for model with age and cellular feedback effects and model with age effect, respectively; <xref ref-type="table" rid="T3"><bold>Table&#xa0;3</bold></xref>). The age dynamics of memory cells in lymphoid tissues were also well described by both models (<xref ref-type="fig" rid="f4"><bold>Figures&#xa0;4B, C</bold></xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Description of age-related cell dynamics for total CD4<sup>+</sup> and total memory CD4<sup>+</sup> CD45RO<sup>+</sup> T-lymphocyte concentrations in blood and lymphoid tissue by the homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics model (<bold>(A)</bold> &#x2013; without age effect on cellular kinetics, <bold>(B)</bold> &#x2013; with age-dependent function inclusion; <bold>(C)</bold> &#x2013; with age- and cell count-dependent function inclusion) (red dots represent observed data as meta-analytical weighted averages with 95% CIs; blue solid lines with shaded area represent predicted means with 95% CIs; purple shaded areas represent data description for neonates, infants and toddlers (0 to 5 years of age)).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1742817-g004.tif">
<alt-text content-type="machine-generated">Graphical representation of age-related cell dynamics for total CD4+ and total memory CD4+ CD45RO+ T-lymphocyte concentrations obtained by three models of homeostatic CD4+ T-lymphocyte cellular kinetics. Panel A shows predictions by model without age effect on cellular kinetics. Panel B shows predictions by model with age effect incorporated. Panel C shows predictions by model with both age and cell count effects incorporated. Each model features observed data, model predictions, and confidence intervals.</alt-text>
</graphic></fig>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Summary of validation and model evaluation results per each step of the homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics model development.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="left">CD4<sup>+</sup> T-lymphocyte subpopulation</th>
<th valign="top" rowspan="2" align="left">Age window</th>
<th valign="top" rowspan="2" align="left">Expected trend</th>
<th valign="top" colspan="3" align="center">Homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics model</th>
</tr>
<tr>
<th valign="top" align="left">(1) without age effect on cellular kinetics</th>
<th valign="top" align="center">(2) with age effect</th>
<th valign="top" align="center">(3) with age and cellular feedback effects</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" colspan="6" align="center"><italic>Model validation results*</italic></th>
</tr>
<tr>
<td valign="top" rowspan="6" align="left">Total CD4<sup>+</sup> T-cells in blood (cells/&#x3bc;L)</td>
<td valign="top" align="left">0&#x2013;1 y. of age</td>
<td valign="top" align="left">Marked increase (0&#x2013;1 years)</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">1&#x2013;18 y. of age</td>
<td valign="top" rowspan="2" align="left">Steep decline</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+</td>
</tr>
<tr>
<td valign="top" colspan="3" align="left">(via the age-dependent thymic involution component)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">18&#x2013;40 y. of age</td>
<td valign="top" rowspan="2" align="left">Stable level</td>
<td valign="top" rowspan="2" align="left">&#x2013;</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" colspan="2" align="left">(via an increase and maintenance of a higher activated T-cell proliferation rate (<inline-formula>
<mml:math display="inline" id="im144"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) compared to newborns)</td>
</tr>
<tr>
<td valign="top" align="left">&gt;40 y. of age</td>
<td valign="top" align="left">Slight increase followed by a gradual decline</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">++<break/>(an age-shifted increase in proliferation rate (<inline-formula>
<mml:math display="inline" id="im145"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) reproduces the slight rise at ~64 years as an adaptation to decreased thymic output)</td>
<td valign="top" align="left">++<break/>(an increase in proliferation rate depending on RTE cells concentration (<inline-formula>
<mml:math display="inline" id="im146"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) reproduces the rise at ~64 years as an adaptation to decreased thymic output; the concentration peak more observable compared to model with age effect included only);</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="5">Total memory CD4<sup>+</sup> T-cells in blood (cells/&#x3bc;L)</td>
<td valign="top" align="left">0&#x2013;1 y. of age</td>
<td valign="top" align="left">Stable level or slight increase</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" align="left">1&#x2013;18 y. of age</td>
<td valign="top" align="left">Stable level</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">++</td>
<td valign="top" align="left">++</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">18&#x2013;40 y. of age</td>
<td valign="top" rowspan="2" align="left">Stable level or gradual increase</td>
<td valign="top" rowspan="2" align="left">&#x2013;<break/>(no cell accumulation is observed)</td>
<td valign="top" align="left">+++</td>
<td valign="top" align="left">+++</td>
</tr>
<tr>
<td valign="top" colspan="2" align="left">(via an increase and maintenance of a higher activated T-cell proliferation rate (<inline-formula>
<mml:math display="inline" id="im147"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) compared to newborns)</td>
</tr>
<tr>
<td valign="top" align="left">&gt;40 y. of age</td>
<td valign="top" align="left">Marked increase followed by a decline</td>
<td valign="top" align="left">&#x2013;<break/>(no cell accumulation is observed)</td>
<td valign="top" align="left">+<break/>(an age-shifted increase in na&#xef;ve cells proliferation rate (<inline-formula>
<mml:math display="inline" id="im148"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and a decrease in the differentiation rate of central-memory to effector-memory cells reproduce the rise at ~64 years)</td>
<td valign="top" align="left">+<break/>(an increase in na&#xef;ve cells proliferation rate depending on RTE cells concentration (<inline-formula>
<mml:math display="inline" id="im149"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and a decrease in the differentiation rate of central-memory to effector-memory cells reproduce the rise at ~64 years; the concentration peak more observable compared to model with age effect included only)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Total memory CD4<sup>+</sup> T-cells in lymphoid tissue (%)</td>
<td valign="top" rowspan="2" align="left">All age groups</td>
<td valign="top" rowspan="2" align="left">Initial steep increase followed by a gradual rise</td>
<td valign="top" rowspan="2" align="left">+/&#x2013;<break/>(no age-dependent variations in cellular kinetic processes were incorporated in the model)</td>
<td valign="top" align="left">+</td>
<td valign="top" align="left">+</td>
</tr>
<tr>
<td valign="top" colspan="2" align="left">(via an increase and maintenance of a higher activated T-cell proliferation rate (<inline-formula>
<mml:math display="inline" id="im150"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) compared to newborns)</td>
</tr>
<tr>
<th valign="top" colspan="6" align="center"><italic>Model evaluation results**</italic></th>
</tr>
<tr>
<td valign="top" align="left">Total CD4<sup>+</sup> T-cells in blood, lymphoid tissue, gastro-intestinal tract and lungs (cells)</td>
<td valign="top" align="left">All age groups</td>
<td valign="top" align="left"/>
<td valign="top" rowspan="5" align="left">A single peak in cell counts is observed during early childhood (around 5 years of age); the age-related cell dynamics closely follow the dynamics of thymic output.</td>
<td valign="top" colspan="2" align="left">Three phases of age-dependent dynamics are distinguished; each phase exhibits a characteristic rise, peak, and subsequent decline in cell counts: 1) 0&#x2013;18 years old; 2) 18&#x2013;50 years old; and 3) &gt;50 years old.</td>
</tr>
<tr>
<td valign="top" align="left">RTE T-cells in blood, lymphoid tissue, gastro-intestinal tract and lungs (cells)</td>
<td valign="top" align="left">All age groups</td>
<td valign="top" align="left"/>
<td valign="top" colspan="2" align="left">Cell counts increase sharply during the first years of life and remain at high levels until approximately 20&#x2013;25 years of age; thereafter, cell numbers gradually decline as a result of thymic involution.</td>
</tr>
<tr>
<td valign="top" align="left">Naive T-cells in blood, lymphoid tissue, gastro-intestinal tract and lungs (cells)</td>
<td valign="top" align="left">All age groups</td>
<td valign="top" align="left"/>
<td valign="top" colspan="2" align="left">Three phases are observed for na&#xef;ve T cells (1) 0&#x2013;18 years old; 2) 18&#x2013;50 years old; and 3) &gt;50 years old): the first peak (at ~4 years old) is driven by the increased thymic output; the second (at ~40 years old) reflects the adaptation of RTE cell survival to reduced thymic output; and the third (at ~64 years old) is associated with the adaptation of na&#xef;ve cell proliferation to the decreased number of RTE cells.</td>
</tr>
<tr>
<td valign="top" align="left">Central- and effector-memory T-cells in blood, lymphoid tissue, gastro-intestinal tract and lungs (cells)</td>
<td valign="top" align="left">All age groups</td>
<td valign="top" align="left"/>
<td valign="top" colspan="2" align="left">Three phases are observed for central- and effector-memory T cells, with a gradual increase in concentration up to approximately 64 years of age, followed by a subsequent decline</td>
</tr>
<tr>
<td valign="top" align="left">Effector T-cells in blood, lymphoid tissue, gastro-intestinal tract and lungs (cells)</td>
<td valign="top" align="left">All age groups</td>
<td valign="top" align="left"/>
<td valign="top" colspan="2" align="left">Effector T cells exhibit age-related dynamics similar to those of na&#xef;ve T cells</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>* Model validation results are presented on <xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>; ** Evaluation of age dynamics of cell counts is shown on <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;11</bold></xref>-<xref ref-type="supplementary-material" rid="SM1"><bold>15</bold></xref>; y. &#x2013; years; n/a &#x2013; not available;</p></fn>
<fn>
<p>+++ &#x2014; complete overlap between observed and predicted 95% CIs (100% of cases); ++ &#x2014; overlap between observed and predicted 95% CIs in &gt;75% of cases or the absolute difference between observed and predicted 95% CI limits &#x2264;30% of the observed value (100% of cases); + &#x2014; overlap between observed and predicted 95% confidence intervals in &gt;50% of cases or the difference between observed and predicted 95% CI limits &#x2264;30% of the observed value in &gt;50% of cases; +/&#x2013; &#x2014; overlap between observed and predicted 95% CIs in &gt;20% of cases or the difference between observed and predicted 95% CI limits &#x2264;30% of the observed value in &gt;20% of cases; &#x2013; &#x2014; overlap between observed and predicted 95% CIs in&lt;20% of cases and the difference between observed and predicted 95% CI limits &#x2264;30% of the observed value in&lt;20% of cases within the selected age range.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>In terms of describing total CD4<sup>+</sup> T-lymphocyte absolute cell counts in organs (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;11</bold></xref>), the model performed well, as compared to estimates of immune cell distributions (<xref ref-type="bibr" rid="B60">60</xref>). Estimates of total T-cell counts, as obtained by Sender and colleagues, were 8*10<sup>9</sup>, 3.6*10<sup>11</sup>, 1.7*10<sup>10</sup> and 1.3*10<sup>10</sup> cells in, respectively, blood, lymphoid organs, the gastro-intestinal tract and lungs (<xref ref-type="bibr" rid="B60">60</xref>). Considering CD4<sup>+</sup>/CD8<sup>+</sup> ratio estimates of ~2.0 for blood and lymphoid tissue and of ~1.0 for peripheral organs (<xref ref-type="bibr" rid="B18">18</xref>), the CD4<sup>+</sup> T-lymphocyte cell counts were ~ 5.3*10<sup>9</sup>, ~ 2.4*10<sup>11</sup>, ~ 8.5*10<sup>9</sup> and 6.5*10<sup>9</sup> cells in, respectively, blood, lymphoid organs, the gastro-intestinal tract and lungs. The maximum CD4<sup>+</sup> T-lymphocyte cell count predicted by the homeostatic model for these compartments reached, respectively, 5.09*10<sup>9</sup> (95% CI: [4.85*10<sup>9</sup>; 5.33*10<sup>9</sup>]), 2.02*10<sup>11</sup> (95% CI: [1.91*10<sup>11</sup>; 2.12*10<sup>11</sup>]), 8.25*10<sup>9</sup> (95% CI: [7.84*10<sup>9</sup>; 8.65*10<sup>9</sup>]) and 4.14*10<sup>9</sup> (95% CI: [3.78*10<sup>9</sup>; 4.58*10<sup>9</sup>]) cells (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;11C</bold></xref>). The percentage differences between predicted mean of maximum CD4<sup>+</sup> T-cell count and observed estimates were 4.0%, 16%, 3.0% and 36% for blood, lymphoid organs, the gastro-intestinal tract and lungs, respectively. Overall, these accurate validation results demonstrated the ability of the homeostatic model to capture both specific and total subpopulation age-related changes.</p>
<p>Age-related changes in absolute cell counts in organs, specific to CD4<sup>+</sup> T-cell subsets, were also fully examined (see <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;12</bold></xref>-<xref ref-type="supplementary-material" rid="SM1"><bold>15</bold></xref>). Three distinct phases can be distinguished in age dynamics for nearly all subpopulations, based on changes in number of cells: 1) 0&#x2013;18 years old; 2) 18&#x2013;50 years old; and 3) &gt;50 years old. In a first phase, a sharp increase in cell numbers with subsequent decline was observed for less differentiated CD4<sup>+</sup> T-cells (RTE and naive), with a maximum being reached at ~4.0 years after birth (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;13C</bold></xref> &#x2013; RTE and Naive). Cell counts for more differentiated counterparts increased gradually and were saturable (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;13C</bold></xref> &#x2013; Central-memory, Effector-memory, and Effector). Such growth in cell numbers would correspond to an increase in thymic output in the first years of life, &#x2018;back-filling&#x2019; the human body with immune cells. The second phase was characterized by a gradual cell count expansion, from 18 years of age up to 40 years of age (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;13C</bold></xref>). From 40 to 50 years of age, counts of less differentiated cells decreased (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;13C</bold></xref><bold>&#x2013;</bold> RTE and Na&#xef;ve), while more differentiated subsets remained stable (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;13C</bold></xref> &#x2013; Effector-memory and Effector) or continued to increase (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;13C</bold></xref> &#x2013; Central-memory). Such behavior may be explained by the attainment of a consistently high level of activated cell proliferation (<inline-formula>
<mml:math display="inline" id="im151"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;5A</bold></xref>), after 18 years of age, which would contribute to the fact that clonal expansion (<inline-formula>
<mml:math display="inline" id="im152"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) exerts its most significant influence on cell age-dependent homeostasis (see Section 3.4.3 for sensitivity analysis results). For the third stage, an increase in cell counts at ~ 64 years of age was observed for all subpopulations except RTE cells. This may correspond to an adaptation of na&#xef;ve T-cell proliferation upon diminished thymic output (<inline-formula>
<mml:math display="inline" id="im153"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;7A, B)</bold></xref>, which is observed after ~50 years of age. Upon reaching a peak during this third phase, cell numbers declined for the remaining years of life. Similar behaviors of age dynamics across these three phases were observed for blood, the gastro-intestinal tract, and the lungs (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;12</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>14</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>15</bold></xref>).</p>
</sec>
<sec id="s3_4_2">
<label>3.4.2</label>
<title>Prediction of effects of homeostasis perturbations</title>
<p>The model&#x2019;s ability to describe the dynamic behavior of CD4<sup>+</sup> T-lymphocytes was assessed based on data on total and na&#xef;ve cell concentrations from patients who underwent complete thymectomy. An exploratory analysis of the collected data is depicted in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;16</bold></xref>. Data were grouped according to age at thymectomy procedure, into 6 groups: 1) 0 to 1 month; 2) 1 to 2 months; 3) 2 months to 1.0 year; 4) 1.0 to 1.5 years; 5) 1.5 to 3.0 years; 6) greater than 3 years of age. For patients who were thymectomized early after birth or during infancy (groups 1-3), short-term dynamical changes of total CD4<sup>+</sup> T-lymphocyte concentrations in blood are presented for the first 5 years of life (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;16A</bold></xref>). For the later thymectomy ages (groups 3-6), CD4<sup>+</sup> na&#xef;ve T-lymphocyte concentrations in blood are available for the adulthood period of 20&#x2013;30 years of age, enabling a long-term evaluation of effects incurred by thymectomy (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;16B</bold></xref>).</p>
<p>Model-based results following simulated thymectomy conditions are presented in <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5</bold></xref>. After &#x201c;switching-off&#x201d; the inflow of mature T-cells into the periphery, the number of CD4<sup>+</sup> T-cells sharply decreased in the first 2 years of life. The magnitude of cell number decreases fully corresponded to baseline values of cell counts prior to thymectomy. While CD4<sup>+</sup> T-lymphocyte blood concentrations increased during infancy, as observed from the data (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;16A</bold></xref>, red dots) and model predictions (<xref ref-type="fig" rid="f5"><bold>Figures&#xa0;5A, C</bold></xref>, red curve), the implications of thymus gland removal directly depended on the age of thymectomy. The short-term dynamic of cell concentrations was well described by the model, with included relationships between homeostatic processes and cell concentrations (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5C</bold></xref>), as compared to the model which accounted only for an age effect (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5A</bold></xref>). This exercise supported the evidence that empirical age functions do not allow for a full accounting of strong perturbations in cell homeostasis, over a range of several years. It further indicated the validity of adapting the model structure by incorporating cellular feedback loops. However, the homeostatic model did not fully capture long-term consequences of thymectomy (<xref ref-type="fig" rid="f5"><bold>Figures&#xa0;5B, D</bold></xref>), where the observed cell concentrations were close to the values found in healthy non-thymectomized subjects - especially in the case of late-age thymectomy.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Prediction of total and na&#xef;ve CD4<sup>+</sup> T-lymphocyte concentration dynamics after complete thymectomy using the homeostatic model (<bold>(A, B)</bold> &#x2013; model with inclusion of age-dependent functions; <bold>(C, D)</bold> &#x2013; model with inclusion of age- and cell count-dependent functions; dots depict individual datapoints from thymectomized subjects; lines illustrate typical model predictions for each data source; color represents group of subjects, according to the age of thymus gland removal; red line indicates typical model-based predictions for healthy, non-thymectomized subjects).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1742817-g005.tif">
<alt-text content-type="machine-generated">Graphs illustrating total and na&#xef;ve CD4+ T-lymphocyte cellular kinetics after thymectomy obtained by model with age effect only and with both age and cell count effects incorporated. Panels A and C display total CD4+ T-cell blood concentrations by age up to 10 years, and panels B and D show CD4+ na&#xef;ve T-cell blood concentrations by age up to 30 years. Different thymectomy age groups are color-coded, with the typical model prediction for healthy subjects represented in red.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_4_3">
<label>3.4.3</label>
<title>Sensitivity analysis results</title>
<p>As an integral part of model evaluation, a sensitivity analysis was performed, in order to assess how an arbitrary change in model parameters would impact both cellular kinetics homeostasis and age-related changes. Results from a global sensitivity analysis for blood concentrations of specific CD4<sup>+</sup> T-cell subsets are presented in <xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6</bold></xref>. Homeostasis of lesser differentiated subsets (<xref ref-type="fig" rid="f6"><bold>Figures&#xa0;6A, B</bold></xref>) was highly impacted by single-positive thymocyte homeostasis (|PRCC| &#x2265; 0.5). For RTE CD4<sup>+</sup> T-lymphocytes, the transition parameter <inline-formula>
<mml:math display="inline" id="im154"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>_</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, as well as age-related changes of transition in lymphoid tissue (<inline-formula>
<mml:math display="inline" id="im155"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im156"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) had a great impact on the homeostasis of these cells (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6A</bold></xref>). For na&#xef;ve CD4<sup>+</sup> T-lymphocytes, the following homeostatic processes &#x2013; differentiation from precursor RTE cells, proliferation, death, differentiation to activated cells after antigen encounter and transitions between blood and lymphoid tissue &#x2013; played a notable role in influencing na&#xef;ve cell kinetics (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6B</bold></xref>). Remarkably, the magnitude of the influence changed with age. The impact of single-positive cell differentiation, death and export to the periphery was less observable for adults and elderly, as compared to subjects in their first years of life. The same behavior was revealed for na&#xef;ve T-cell homeostatic processes. However, thymocyte proliferation displayed the opposite behavior, indicating an increasing dependence of mature T cell homeostasis on thymocyte proliferative activity, as thymic involution progresses. Moreover, the impact of the magnitude of na&#xef;ve CD4<sup>+</sup> T-cell proliferation relative decrease (<inline-formula>
<mml:math display="inline" id="im157"><mml:mrow><mml:msubsup><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>&#xa0;</mml:mo></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula>) became more pronounced in elderly as compared to younger subjects, illustrating the stronger influence of homeostatic proliferation vs. thymic output on immune cell homeostasis at more advanced ages.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Global sensitivity analysis using a PRCC-based method: Blood concentration of RTE <bold>(A)</bold>, na&#xef;ve <bold>(B)</bold>, activated <bold>(C)</bold>, central-memory <bold>(D)</bold>, effector-memory <bold>(E)</bold> and effector <bold>(F)</bold> CD4<sup>+</sup> T-lymphocytes for five age levels (0, 1, 20, 50, 80 years of age) (asterisk (*) indicates |PRCC| &#x2265; 0.5).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1742817-g006.tif">
<alt-text content-type="machine-generated">Heatmaps depicting sensitivity analysis results for blood concentrations of various CD4+ T-cell subtypes (RTE, Naive, Activated, Central-memory, Effector-memory, Effector) across different ages (1, 20, 50, 80). The colors range from green to red, indicating different PRCC values, with annotations for thymocytes homeostasis, CD4+ T-cell homeostasis, and age and cell count-dependent function parameters. Each panel (A-F) represents a different T-cell subtype.</alt-text>
</graphic></fig>
<p>The greatest influence on more differentiated CD4<sup>+</sup> T-lymphocyte subpopulations was exerted by proliferation (<inline-formula>
<mml:math display="inline" id="im158"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) and differentiation (<inline-formula>
<mml:math display="inline" id="im159"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) rates of activated T-cells (<xref ref-type="fig" rid="f6"><bold>Figures&#xa0;6D&#x2013;F</bold></xref>). The proliferation rate of activated CD4<sup>+</sup> T-lymphocytes, <inline-formula>
<mml:math display="inline" id="im160"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, represents the magnitude of clonal expansion, while the differentiation rate, <inline-formula>
<mml:math display="inline" id="im161"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, stands for the activity of infectious processes. Results of the sensitivity analysis indicated that antigen exposure throughout human life played a major role in influencing memory and effector cell counts. Lifelong antigen exposure had a much stronger effect on maintaining cell homeostasis than thymic output or the homeostatic regulation of precursor na&#xef;ve, memory, and effector cells. The significant influence of the maximum relative decrease in the transition rate of effector CD4<sup>+</sup> T-cells from lymphoid tissue to blood, <inline-formula>
<mml:math display="inline" id="im162"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> on effector cells count became pronounced in elderly subjects (<xref ref-type="fig" rid="f6"><bold>Figure&#xa0;6F</bold></xref>). This makes cell circulation properties to be one of the key determinants of effector cells reaching their sites of action. No major differences were found, in the global sensitivity analysis, for cell counts of specific subpopulations in lymphoid tissue, the gastro-intestinal tract, and the lungs (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;17</bold></xref>-<xref ref-type="supplementary-material" rid="SM1"><bold>19</bold></xref>).</p>
<p>Moreover, a likelihood profiling analysis was used to evaluate the validity of selected model parameter values. Likelihood profiling was conducted for the parameters <inline-formula>
<mml:math display="inline" id="im163"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im164"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, whose values had non-informative priors, to ensure obtaining the best estimate of the objective function for the proposed parameter values (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;20</bold></xref>). Fixing the parameter at any value in ranges of [0.0002; 0.01] d<sup>-1</sup> for <inline-formula>
<mml:math display="inline" id="im165"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and [0.03; 5] d<sup>-1</sup> for <inline-formula>
<mml:math display="inline" id="im166"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> led to the same likelihood function value, indicating the sensibleness of selected values. This conclusion was also confirmed by the global sensitivity analysis, whereby &#xb1; 25% changes in these parameters did not have any significant influence on cellular homeostasis (<xref ref-type="fig" rid="f6"><bold>Figures&#xa0;6B, D</bold></xref>).</p>
<p>As the final model included intercellular regulatory mechanisms of na&#xef;ve T-cell proliferation and RTE cell death adaptation to decreased thymic output, an additional quantification of the contribution of the proposed compensatory mechanisms was performed. Specifically, CD4<sup>+</sup> T-lymphocyte numbers in lymphoid organs were simulated under three scenarios in which two state-dependent adaptations were selectively removed: (1) no adaptation of na&#xef;ve T-cell proliferation; (2) no adaptation of the RTE death rate; and (3) neither adaptation, while keeping all other model components unchanged. Simulations of CD4<sup>+</sup> T-cell dynamics in lymphoid organs showed that removing RTE death adaptation resulted in an ~20% reduction in CD4<sup>+</sup> T-cell numbers at 20 years of age. Removing na&#xef;ve proliferation adaptation led to an ~50% reduction in CD4<sup>+</sup> T-cell numbers at 80 years of age relative to the full model. When both adaptations were disabled simultaneously, CD4<sup>+</sup> T-cell numbers declined by more than 80%, indicating that these mechanisms jointly contribute to maintaining CD4<sup>+</sup> T-cell homeostasis over the lifespan (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;21</bold></xref>).</p>
<p>The two-parameter response surfaces (contour plots) revealed distinct interaction patterns across the analyzed parameter pairs for CD4<sup>+</sup> T-lymphocyte numbers in lymphoid organs (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;22</bold></xref>). In terms of <inline-formula>
<mml:math display="inline" id="im167"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> vs. <inline-formula>
<mml:math display="inline" id="im168"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;22B</bold></xref>) interaction, nearly vertical iso-contours indicated that the output was dominated by proliferation of na&#xef;ve CD4<sup>+</sup> T-cells, with minor modulation only via the differentiation rate of the effector-memory subset. In contrast, strongly tilted and curved contours in the <inline-formula>
<mml:math display="inline" id="im169"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> vs. <inline-formula>
<mml:math display="inline" id="im170"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> plane (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;22A</bold></xref>) demonstrated compensatory behavior, where increases in the na&#xef;ve CD4<sup>+</sup> T-cell proliferation rate could compensate for changes in the differentiation rate of central-memory cells, to maintain similar CD4<sup>+</sup> T-cell levels; the curvature suggested non-additive interactions. The <inline-formula>
<mml:math display="inline" id="im171"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> vs. <inline-formula>
<mml:math display="inline" id="im172"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mo>&#xa0;</mml:mo></mml:mrow></mml:math></inline-formula> surfaces (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;22C</bold></xref>) showed predominantly vertical contours across ages, suggesting that CD4<sup>+</sup> T-cell numbers in lymphoid tissue are much more sensitive to central-memory cell proliferation vs. effector-memory, with only weak pairwise interactions apparent in restricted regions of the parameter space. For parameter pairs involving <inline-formula>
<mml:math display="inline" id="im173"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;22D, E</bold></xref>), a threshold-like influence nature was observed, with low CD4<sup>+</sup> T-cell numbers over a broad region followed by a rapid increase once <inline-formula>
<mml:math display="inline" id="im174"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> exceeded a critical range, after which the influence of the paired parameter (<inline-formula>
<mml:math display="inline" id="im175"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im176"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) became more apparent. The <inline-formula>
<mml:math display="inline" id="im177"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> vs. <inline-formula>
<mml:math display="inline" id="im178"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mo>&#xa0;</mml:mo></mml:mrow></mml:math></inline-formula> surface showed the clearest compensatory structure, with diagonal iso-line contours consistent with strong parameter interdependence (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;22F</bold></xref>). Overall, the qualitative interaction patterns were preserved across ages, while the steepness and curvature of response surfaces varied, indicating age-dependent sensitivity of lymphoid CD4<sup>+</sup> T-cell numbers to specific parameter combinations.</p>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p><italic>In vivo</italic> stable isotope labeling remains a gold standard in the investigation of T-lymphocyte kinetics (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Comprehensive reviews of T-cell kinetic estimates were provided by two groups, Borghans and de Boer (<xref ref-type="bibr" rid="B5">5</xref>) and Macallan et&#xa0;al. (<xref ref-type="bibr" rid="B12">12</xref>), summarizing half-life estimates, generation and proliferation rates for total and specific cell subpopulations obtained over two decades, based on deuterium-labelled experimental data analyses. These data were essential in defining experimental estimates of parameters in the present model (see <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Tables&#xa0;2</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>3</bold></xref>), enabling validation of the model in its dynamic representation of current knowledge on lymphocyte kinetics. The modeling approaches used to describe labeled data kinetics included predominantly ODE-based models, where kinetic heterogeneity in cell populations was accounted for using a compartmental approach (<xref ref-type="bibr" rid="B62">62</xref>). More computationally intense methodologies such as physiologically-based pharmacokinetic modeling (PBPK) (<xref ref-type="bibr" rid="B63">63</xref>) and agent-based modeling (ABM) (<xref ref-type="bibr" rid="B64">64</xref>) have also been proposed for labeled data description and the derivation of kinetic estimates. However, while these modeling approaches may provide quantitative insights on cell homeostasis, their ability to extrapolate results and to predict cell kinetics under homeostatic alterations is limited. As for the present homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetic model, data on steady-state cell counts and concentrations were used, rather than dynamics of labelled cells over limited labeling periods. It provided further options to consider mechanistic aspects of cell behaviors and interactions. The proposed mechanistic model thus incorporated T-lymphocyte kinetics estimates from labelling experiments as well as steady-state information of kinetically heterogenous populations, and enabled predictive simulations of physiologically relevant scenarios.</p>
<p>The developed multiscale homeostatic model included age-related dependencies at various levels: 1) in the thymus compartment, by capturing involution processes (<inline-formula>
<mml:math display="inline" id="im179"><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im180"><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>); 2) on blood volume, representative of organism growth (<inline-formula>
<mml:math display="inline" id="im181"><mml:mrow><mml:mi>B</mml:mi><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>); 3) on proliferation (<inline-formula>
<mml:math display="inline" id="im182"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im183"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) and death (<inline-formula>
<mml:math display="inline" id="im184"><mml:mrow><mml:msub><mml:mi>&#x3bc;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) rates of less differentiated T-cell subsets, indicative of adaptation to decreased thymic output and memory cell longevity maintenance; 4) on further differentiation of T-cell subsets (<inline-formula>
<mml:math display="inline" id="im185"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im186"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>), by capturing the kinetic heterogeneity of memory CD4<sup>+</sup> T-cell subpopulations; and 5) on transitions of circulating cells (<inline-formula>
<mml:math display="inline" id="im187"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im188"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im189"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im190"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im191"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im192"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im193"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula>
<mml:math display="inline" id="im194"><mml:mrow><mml:msub><mml:mi>&#x3c9;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>)), representative of changes in organ perfusion and permeability throughout life. In terms of capturing, overall, age-related changes in T-lymphocyte numbers, model results were in line with the staging proposed in a recent review by Baliu-Pique et&#xa0;al., distinguishing developmental (0&#x2013;20 years of age), middle age (20&#x2013;65 years of age) and older (&gt;65 years of age) stages (<xref ref-type="bibr" rid="B13">13</xref>). We observed and quantified similar behavior of age dynamics for total CD4<sup>+</sup> T-lymphocytes, as well as identified cell count changes within these stages. Specifically, we identified the biphasic nature of CD4<sup>+</sup> T-cell numbers within the &#x201c;middle age&#x201d; stage, with two peaks at ~ 40 and ~ 64 years of age.</p>
<p>Numerous studies have investigated changes in immune homeostasis during healthy aging (<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B66">66</xref>); several studies evaluated such changes using mathematical modeling approaches (<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>). Firstly, the process of thymic involution has been widely explored and described using various model structures, from the straightforward exponential decay function (<xref ref-type="bibr" rid="B69">69</xref>) to mechanistic ODE-based thymocyte population dynamics models accounting for a maximal carrying capacity in thymic niches (<xref ref-type="bibr" rid="B27">27</xref>). The data most often used for modeling age-related changes are signal joint TCR excision circles and stable isotope labeling data. Despite the heterogeneity among modeling approaches to thymus homeostasis, the parameter values used in the present thymus sub-model fall within reported ranges, and detailed benchmarking is provided in our previous study (<xref ref-type="bibr" rid="B27">27</xref>). One open issue is whether the compensatory homeostatic proliferation in instances of low cell numbers due to, e.g., aging, HIV-infection, or other lymphocytopenia conditions, which is typically observed in rodents, may also hold in humans (<xref ref-type="bibr" rid="B70">70</xref>). From a immuno-physiological point of view, this compensatory behavior can be understood in the context of cytokine-regulated T-cell homeostasis. In particular, IL-7/IL-7R signaling is a central regulator of na&#xef;ve T-cell survival and low-level homeostatic proliferation, and IL-7 availability is shaped by stromal production and T-cell consumption, providing a plausible biological substrate for effective compensation when thymic output declines (<xref ref-type="bibr" rid="B29">29</xref>). In the Westera et&#xa0;al. modeling study, no significant peripheral homeostatic compensation in na&#xef;ve CD4<sup>+</sup> T-lymphocytes was identified in elderly (66&#x2013;72 years of age) vs. young healthy subjects (20&#x2013;25 years of age), despite a decreased thymic output (<xref ref-type="bibr" rid="B67">67</xref>). These results contradicted previous experimental evidence of an enhanced percentage of the Ki-67<sup>+</sup> proliferation marker in na&#xef;ve CD4<sup>+</sup> T-cells in elderly subjects with a reduced pool size of immune cells (<xref ref-type="bibr" rid="B71">71</xref>). Our modeling results propose that na&#xef;ve CD4<sup>+</sup> T-lymphocyte proliferation significantly increases with age. Moreover, the dependency of na&#xef;ve cell proliferation on RTE cell concentration was taken into account and parameterized. However, our modeling results are still in line with the Westera et&#xa0;al. findings. The point estimates of CD4<sup>+</sup> na&#xef;ve T-cell proliferation rates for aged and young subjects were 0.07 and 0.04%*d<sup>-1</sup>, respectively, indicating an aged/young ratio of 1.75 (<xref ref-type="bibr" rid="B67">67</xref>). A comparable ratio (1.7) was calculated from the model-based results, with <inline-formula>
<mml:math display="inline" id="im195"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:mn>70</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> = 0.0012 d<sup>-1</sup> and <inline-formula>
<mml:math display="inline" id="im196"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:mn>23</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> = 0.0007 d<sup>-1</sup>. Thymic output was not sufficient to maintain immune cell numbers at their respective levels. The homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics model calibrated on data from the first years of life - which included only thymic involution and blood volume as age-dependent processes - provided a precise description of blood concentration data for the first years of life, while it failed to adequately capture age dynamics for all cell subpopulations. Moreover, the maximal total number of CD4<sup>+</sup> T-cells in lymphatic tissue predicted by the homeostatic model was almost five-fold less than the number reported in the literature [~5*10<sup>10</sup> cells vs. ~ 2.4*10<sup>11</sup> cells (<xref ref-type="bibr" rid="B60">60</xref>)]. These model-based findings point to a key role of na&#xef;ve T-lymphocyte proliferation adaptation and of increased clonal expansion activity, to maintain immune cell homeostasis throughout human life.</p>
<p>The immune cell repertoire investigation using data from patients who underwent thymus gland removal was another rich source of evidence on cell homeostasis (<xref ref-type="bibr" rid="B72">72</xref>). Partial or complete thymectomies are surgical procedures motivated by cardiac operations in early childhood, as well as treatment of myasthenia gravis or thymomas. The extent of thymic tissue removal as well as age of thymectomy are principal determinants of T-cell numbers and immune system functionality preservation and restoration. Numerous experimental studies have evaluated numbers of total and na&#xef;ve CD4<sup>+</sup> T-lymphocytes coupled with other markers, in thymectomized subjects (<xref ref-type="bibr" rid="B72">72</xref>). According to these data, upon complete thymectomy, a substantial decrease in cell concentrations in the first 5 years following the procedure is observed. However, after 20 years, subjects who underwent complete thymus removal age 3 or older exhibited na&#xef;ve CD4<sup>+</sup> T-lymphocyte concentrations close to reference values found in non-thymectomized healthy subjects.</p>
<p>The mechanistic model presented here provides an opportunity to investigate the observed cell dynamics and to identify potential regulatory mechanisms which may explain homeostatic adaptation. The homeostatic model of CD4<sup>+</sup> T-lymphocyte cellular kinetics with incorporation of an age effect was not successful in describing neither short-term nor long-term cell concentration dynamics. This underlines the necessity to take into account homeostatic regulations, without which cell concentrations may drop close to zero, 10 years after a thymectomy procedure. Incorporation of RTE cell concentration feedback on na&#xef;ve cell proliferation in the model resulted in an adequate description of short-term cell dynamics, which was supported by elevated Ki-67<sup>+</sup> data in thymectomized subjects, in their first years following thymectomy (<xref ref-type="bibr" rid="B73">73</xref>). However, this adaptive mechanism of na&#xef;ve CD4<sup>+</sup> T-cell proliferation was not sufficient to capture long-term restoration of immune cell counts; additional regulatory mechanisms needed to be included. While some researchers have reported re-growth of thymic tissue, based on MRI scans, the extent of restored thymopoiesis remains in question (<xref ref-type="bibr" rid="B28">28</xref>). Considering the high impact of thymic output on immune homeostasis during the first years of life, both in terms of cell accumulation and the encountering of novel antigens, the present modeling results support the notions of avoiding full thymic removal and, therefore, preserving some minimal amount of thymic tissue during surgery within the first year of life, whenever feasible and appropriate (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B72">72</xref>). The proposed mechanistic model indeed accounts for the age of thymectomy, and our data analysis showed that one may make more significant inferences from thymectomy data as compared to data of single experimental studies. With this mechanistic inclusion of the thymus gland in the model, simulation-based investigations of various clinically relevant scenarios, such as the extent of thymectomy or gradual thymic re-growth features, as well as other perturbations, become feasible.</p>
<p>In addition to the homeostatic adaptation to declining cell numbers, an important complementary aspect of immune aging is the system&#x2019;s adaptation to increasing antigenic load and, consequently, to periods of expanded T-cell numbers. The proposed model already captures several key nonlinear homeostatic constraints, including growth control of thymocyte subpopulations, limited peripheral clonal expansion, and an RTE-dependent feedback affecting RTE death and na&#xef;ve proliferation. At the same time, the current formulation is focused on a baseline, age-dependent homeostasis and does not explicitly consider additional regulatory mechanisms such as cytokine-modulated survival or activation-induced cell death, which are expected to become particularly relevant under strong immune stimulation or infection. Incorporating these processes is a natural extension of the presented framework and would require coupling the homeostatic module to explicit antigen- or infection-driven dynamics. In addition to expanding the proposed physiology-based model to describe infection-driven lymphocyte dynamics, the developed model may also be used in vaccination studies. By providing age-specific baselines for na&#xef;ve precursor availability and memory maintenance in blood and lymphoid organs, it offers a mechanistic scaffold for comparing vaccine responses across the lifespan. To extend the model for vaccination studies, an antigen-driven activation module should be added; adjuvant effects may be implemented via parameter changes affecting activation, clonal expansion, differentiation to memory, and survival of CD4<sup>+</sup> T cells. Such an extension would enable an <italic>in silico</italic> evaluation of the heterogeneity of age-specific response magnitude and durability, and support optimization of vaccine dose and scheduling strategies.</p>
<p>In parallel, thymic involution was represented through an effective age-dependent reduction in the maximum carrying capacity of the thymic cortex and medulla. This parameterization was informed by empirical observations of age-associated changes in thymus weight and the decline of the true thymic epithelial space (TES), providing a physiologically grounded description at the level of organ function. The biological basis of TES loss is consistent with age-related remodeling of thymic stromal cells, supported by transcriptomic and single-cell studies reporting broad shifts in TES programs and implicating molecular and endocrine regulators (e.g., FGF21, lamin-B1, and sex steroid hormones) (<xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>). Because these drivers were not modeled explicitly, the proposed framework is not designed to predict the effects of targeted hormonal or epigenetic interventions directly; instead, their aggregate influence is reflected indirectly in the inferred age-dependent capacity functions. Heterogeneity of memory T-cells homeostasis and aging subsets represent another recurring question in immunology research. Modeling research based on deuterated glucose labeling data, as proposed by Macallan et&#xa0;al., indicated differences in turnover rates between CD45RO<sup>+</sup>CCR7<sup>+</sup> central-memory and CD45RO<sup>+</sup>CCR7<sup>&#x2013;</sup> effector-memory CD4<sup>+</sup> T-cells, with higher proliferation rates for the latter (<xref ref-type="bibr" rid="B36">36</xref>). Moreover, studies in mice, as performed by Gossel et&#xa0;al., highlighted both 1) kinetic heterogeneity in memory subsets; and 2) longevity dependence on the recruitment of na&#xef;ve cells into the memory compartment (<xref ref-type="bibr" rid="B15">15</xref>). The first aspect has been captured in the present model as central-memory <inline-formula>
<mml:math display="inline" id="im197"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and effector-memory <inline-formula>
<mml:math display="inline" id="im198"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> CD4<sup>+</sup> T-cells, with distinct turnover rates, according to the proposed values of proliferation and differentiation parameters. The second aspect was supported by a sensitivity analysis, which identified activated cell homeostasis as the most impactful process on the maintenance of memory cells and the point estimates of differentiation rates to and from the central-memory subset. Age-related changes have also been observed in memory T-cell homeostasis. The full memory CD4<sup>+</sup> T-cell subpopulation tends to accumulate throughout human life (<xref ref-type="bibr" rid="B65">65</xref>). The same can be observed from the calibration dataset used in the present model: an accumulation of central-memory and effector-memory cells detected both in blood and peripheral tissues (<xref ref-type="bibr" rid="B18">18</xref>). However, differences between central- and effector-memory cells can be made based on the age dynamics data, where central-memory (CM) cell percentages increased throughout life, while effector-memory (EM) cell percentages started to decline after ~40 years of age. In the present model, such age-related changes in CM and EM cell homeostasis were captured by decreasing age functions for CM and EM differentiation rates (<inline-formula>
<mml:math display="inline" id="im199"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im200"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>). A plausible explanation for the decline in <inline-formula>
<mml:math display="inline" id="im201"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> may relate to the exhaustion and/or senescence of cell accumulation, due to chronic infections during aging (<xref ref-type="bibr" rid="B14">14</xref>), which, when coupled with a higher turnover of EM cells, may lead to a decrease in cell counts. The immunity study in mouse, by Gossel et&#xa0;al., showed a diminished replacement rate of EM CD4<sup>+</sup> T-cells in older adult mice, as compared to younger animals (<xref ref-type="bibr" rid="B15">15</xref>). The authors provided two equally plausible explanations for this phenomenon: the existence of resistant EM CD4<sup>+</sup> T cells; and decreased differentiation from the na&#xef;ve pool. Since the present model was designed to capture immune system homeostasis, which includes experience in encountering foreign antigens over a lifespan, and while the Gossel et&#xa0;al. experiments were conducted in non-infected mice, the <inline-formula>
<mml:math display="inline" id="im202"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> dependency is reflective of EM cells decline.</p>
<p>In terms of heterogeneity in memory cell subsets, one limitation of the present model may reside in the fact that stem cell-like memory T-cells (SCM) were not explicitly represented in the model structure. SCM cells are a long-lived memory cell subpopulation that exhibits higher self-renewal properties than other memory subsets, a multipotent differentiation nature, and further kinetic heterogeneity with two distinct sub-groups: rapidly replaced and long-lived SCMs (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B77">77</xref>). CD95 marker expression has been used to distinguish SCM cells from their na&#xef;ve counterparts (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B52">52</xref>). In the proposed model, the <inline-formula>
<mml:math display="inline" id="im203"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> variable representing the na&#xef;ve CD4<sup>+</sup> T-cell subset was calibrated based on CD45RA<sup>+</sup>/CD45RO<sup>&#x2013;</sup> CCR7<sup>+</sup>/CD62L<sup>+</sup> CD4<sup>+</sup> T-cell quantitative data (<xref ref-type="bibr" rid="B18">18</xref>). Therefore, the model variable describing the na&#xef;ve T-lymphocyte subpopulation contains a subpopulation of SCM cells, along with true na&#xef;ve cells. Based on this consideration, model parameters for the na&#xef;ve subset can be interpreted in a different manner. The homeostatic CD4<sup>+</sup> T-cell kinetic model suggested capturing the &#x201c;steady-state&#x201d; activation of the immune system after the first encounter with an antigen with the na&#xef;ve CD4<sup>+</sup> T-cell differentiation rate parameter, <inline-formula>
<mml:math display="inline" id="im204"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>. Considering the embedding of na&#xef;ve cells with SCM cells within this one model variable, the parameter <inline-formula>
<mml:math display="inline" id="im205"><mml:mrow><mml:msub><mml:mi>&#x3c6;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> may also be reflective of a steady-state transition from na&#xef;ve to SCM cells, without antigen involvement. The na&#xef;ve CD4<sup>+</sup> T-cell proliferation rate parameter, <inline-formula>
<mml:math display="inline" id="im206"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, may also include SCM cell homeostatic properties, such as self-renewal. Owing to the detected age-related changes of the parameter <inline-formula>
<mml:math display="inline" id="im207"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, which were associated with RTE cell concentration dependencies (<inline-formula>
<mml:math display="inline" id="im208"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula>
<mml:math display="inline" id="im209"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mo>_</mml:mo><mml:mi>u</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, the age-associated alterations in SCM cells homeostasis may be presumed to influence <inline-formula>
<mml:math display="inline" id="im210"><mml:mrow><mml:msub><mml:mi>&#x3bb;</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, in addition to the na&#xef;ve T-cell adaptation to a decreased thymic output. Moreover, in spite of kinetic heterogeneity in SCM T-cells (<xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B77">77</xref>), the activated cell model variable, <inline-formula>
<mml:math display="inline" id="im211"><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, could capture the SCM subset with enhanced self-renewal properties. In view of the sensitivity analysis results, whereby activated CD4<sup>+</sup> T-cell homeostasis parameters had the greatest influence on memory subset homeostasis, the impact of SCM cell proliferative activity on long-lived immune memory maintenance was implicitly considered, along with the clonal expansion effect. However, the magnitude of this impact, as well as an overall characterization of SCM T-lymphocyte homeostasis, would require an additional analysis and model expansion by considering &#x201c;true&#x201d; na&#xef;ve CD95<sup>&#x2013;</sup> and SCM CD95<sup>+</sup> subpopulations, along with an inventory of all relevant quantitative data sources pertaining to these phenotypic subsets.</p>
<p>Another limitation of the present analysis is that resident-memory (RM) CD4<sup>+</sup> T-cells, which play a key role in local immunity and immune memory maintenance (<xref ref-type="bibr" rid="B78">78</xref>), were not directly represented in the model structure. Depending on the marker expressions being used for tissue residency, RM CD4<sup>+</sup> cells may constitute 63.9 &#x2013; 92.2% (CD45RO<sup>+</sup>CD69<sup>+</sup>) and 54.1 &#x2013; 75.2% (CD45RO<sup>+</sup>CD103<sup>+</sup>) in the gastro-intestinal tract, and 5.9 &#x2013; 29.3% (CD45RO<sup>+</sup>CD69<sup>+</sup>) and 1.9 &#x2013; 4.5% (CD45RO<sup>+</sup>CD103<sup>+</sup>) in the lungs, relative to the total amount of memory CD4<sup>+</sup> T-cells [calculated in (<xref ref-type="bibr" rid="B18">18</xref>), based on data from (<xref ref-type="bibr" rid="B79">79</xref>)]. Indirectly, the residency of cells in organs was captured by CM and EM cells, which could fail to recirculate, in the respective organs. The incorporation of RM CD4<sup>+</sup> T-cells as a distinct variable would represent one of the next steps in expanding the present model, conditional on the availability of age-dependent data for RM cell percentages in various organs (<xref ref-type="bibr" rid="B79">79</xref>).</p>
<p>The influence of non-immunological factors, such as sex and environmental exposures, which can plausibly modify age-dependent CD4<sup>+</sup> T-cell homeostasis, requires further investigation. Large human studies have reported sex-associated differences in immune aging, including shifts in adaptive immune compartments and na&#xef;ve T-cell features, suggesting that sex may influence the inferred age trends (<xref ref-type="bibr" rid="B80">80</xref>). Mechanistically, sex steroid hormones are recognized contributors to thymic remodeling via effects on thymic epithelial compartments, providing a biological basis for potential sex-specific thymic trajectories (<xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>). In the previously performed systematic review and meta-analysis of age-dependent T-lymphocyte homeostasis, evaluation of sex effects was attempted; however, sex was inconsistently reported across primary sources, thereby limiting statistical power (<xref ref-type="bibr" rid="B18">18</xref>). In a preliminary analysis combining individual observations with known sex and single-sex cohort studies, no significant male&#x2013;female differences were detected in the age dynamics of total lymphocytes and major T-cell counts, while the CD4<sup>+</sup>/CD8<sup>+</sup> T-cell ratio tended to be higher in females without reaching significance (<xref ref-type="bibr" rid="B18">18</xref>). The developed model utilized an age-dependent blood volume function scaled from a published body weight vs. age relationship (<xref ref-type="bibr" rid="B54">54</xref>). Although the underlying model included sex as a covariate, sex-specific scaling was not considered in model calibration because (i) sex was not consistently reported across the data sources used to compile the calibration dataset, and (ii) the aggregated meta-analytic estimates of T-cell counts did not show robust sex differences in the available homeostatic database. At the same time, the developed model can be readily extended by introducing a sex-specific correction factor at the blood-volume parameterization step, enabling sex-specific predictions of T-cell concentrations without altering the cellular kinetic equations. Quantifying sex effects at the level of homeostatic kinetic parameters would, however, require an additional sex-stratified dataset with sufficient longitudinal or age-resolved immunophenotyping. Environmental factors such as the gut microbiome may also shape immune aging through age-associated dysbiosis, altered barrier integrity, and inflammaging (<xref ref-type="bibr" rid="B81">81</xref>); however, assessing these effects would require dedicated datasets.</p>
<p>Several assumptions were made during model development regarding T-cell death rates and transition rates between organs. Death rates for the various CD4<sup>+</sup> T-lymphocyte subpopulations were fixed based on experimental estimates and were assumed to be equal in each physiological compartment, in order to capture immune homeostasis. However, in an active immune response, death rates may vary across different organs, especially for the effector subset with an arguably higher death rate at the site of infection. Another assumption relates to the kinetic transition rates of specific subpopulations in the gastro-intestinal tract and lungs compartments, which were driven by comparable cell percentages for each CD4<sup>+</sup> subpopulation in these compartments. Despite differences in volumetric flow rate of blood between lungs and the gastro-intestinal tract, kinetics of blood cells are comparable, e.g., as approximated from blood cell flow (ml/h) and volume-based (ml) physiological parameters from the Shah and Betts PBPK model (<xref ref-type="bibr" rid="B82">82</xref>). In the present model, the identified age-related changes in T-cell migration &#x2013; namely, a reduced transition from lymphoid tissue to blood and an increased effector CD4<sup>+</sup> transition to peripheral organs &#x2013; reflect mechanisms reported in experimental studies (<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B84">84</xref>). Specifically, aging process contributed not only to a decline in lymph node numbers and lymphatic system deterioration, but also to a decrease in high endothelial venule (HEV) numbers, which further contributed to age-dependent cell migration alterations (<xref ref-type="bibr" rid="B83">83</xref>). The observed increase in effector cell transfer to peripheral sites with age may further correspond to inflammaging processes and increased intestinal mucosal permeability (<xref ref-type="bibr" rid="B84">84</xref>).</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusions</title>
<p>A multiscale mechanistic model of homeostatic CD4<sup>+</sup> T-lymphocyte cellular kinetics was developed, integrating maturation, peripheral differentiation and migration aspects, as well as age-related changes in the homeostasis of various cell subpopulations, from thymocytes to effector cells. A sequential approach to model development was proposed, to subsequently characterize cellular kinetics in newborns, capture age-dependent homeostasis of CD4<sup>+</sup> T-lymphocytes, and evaluate reciprocal cellular influences on homeostasis. An analysis of generalized data, from multiple sources, on cell concentrations in various organs and across narrow age groups, combined with experimental estimates of cellular kinetics enabled a consistent representation of quantitative, age-dependent homeostasis of CD4<sup>+</sup> T-cells and the conduction of <italic>in silico</italic> experiments to evaluate the immune system&#x2019;s behavior following homeostatic disturbances. Age-dependent changes in several processes were identified as significant features of the model for describing CD4<sup>+</sup> T-lymphocyte homeostasis in healthy humans. These processes include na&#xef;ve and activated cell proliferation, RTE cell death, central-memory and effector-memory cell differentiation. In addition, age-dependent cellular transitions from lymphoid tissue to blood and peripheral organs as well as decreased thymocyte egress as a result of thymic involution were identified as significant features to maintain CD4<sup>+</sup> T-lymphocyte homeostasis. A model-based sensitivity analysis revealed that thymocyte homeostasis parameters, as well as the differentiation, proliferation and transition rates of na&#xef;ve CD4<sup>+</sup> T-lymphocytes were the more important processes influencing concentrations of lesser differentiated subpopulations, while for more differentiated memory and effector cells, the extent of clonal expansion appeared to be the most critical process. The degree of influence of the abovementioned processes was found to decrease with age. The compensatory mechanism of an increase in the na&#xef;ve T-cell proliferation rate and a decrease in the RTE cell death rate, in response to a declining number of RTE cells, was essential to capture perturbations in cellular homeostasis. As a result of evaluating the restoration of CD4<sup>+</sup> T-lymphocyte counts upon thymectomy, an increase in na&#xef;ve T-cell proliferation was found to be insufficient to maintain cell counts, decades after the procedure. The present mechanistic model of immunological homeostasis enabled a systematic aggregation of all heterogeneous experimental and clinical information on cell homeostasis and their integration into biological mechanisms, to obtain an accurate, time-dependent description of cell counts in various tissue compartments and to perform quantitative simulations of various clinically relevant scenarios.</p>
<p>The developed homeostatic model of CD4<sup>+</sup> T-lymphocyte cellular kinetics provides a quantitative description of maturation, activation and differentiation of distinct CD4<sup>+</sup> T-cell subpopulations, together with age-related changes in homeostasis. Besides the identification of key alterations in homeostatic processes during aging, the proposed model also provides an instrumental tool for personalized age-conditioned CD4<sup>+</sup> T-lymphocyte immune profiling, which can be further individualized using patient-specific immunophenotyping data, and for generating immune response predictions across the lifespan of healthy individuals. Incorporation of cell transition aspects in the model further provides an opportunity to evaluate local infection scenarios and/or organ-specific immune response dynamics, for example an HIV infection scenario which is known to strongly affect the gastro-intestinal tract. Moreover, the developed model represents a quantitative framework to investigate alterations in cell homeostasis under HIV or other infections, for which questions concerning regulations of the immune system remain unaddressed. For future perspective, the developed model can be used as a core module in a quantitative systems pharmacology platform, for practical use in drug or vaccine development, in accordance with model-informed drug discovery and development (MIDD) principles (<xref ref-type="bibr" rid="B57">57</xref>).</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Material</bold></xref>. Further inquiries can be directed to the corresponding author.</p></sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>VK: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. KP: Writing &#x2013; review &amp; editing, Validation, Funding acquisition, Methodology, Supervision, Conceptualization. GH: Methodology, Conceptualization, Validation, Writing &#x2013; review &amp; editing. GB: Writing &#x2013; review &amp; editing, Supervision, Methodology, Validation, Conceptualization.</p></sec>
<ack>
<title>Acknowledgments</title>
<p>We would like to acknowledge the contribution of all our colleagues at M&amp;S Decisions and the MID3 Research Center at Sechenov University for their continuous support.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>Author KP is an employee and shareholder of Modeling &amp; Simulation Decisions FZ - LLC.</p>
<p>The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that Generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2026.1742817/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2026.1742817/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Swain</surname> <given-names>SL</given-names></name>
<name><surname>McKinstry</surname> <given-names>KK</given-names></name>
<name><surname>Strutt</surname> <given-names>TM</given-names></name>
</person-group>. 
<article-title>Expanding roles for CD4+ T cells in immunity to viruses</article-title>. <source>Nat Rev Immunol</source>. (<year>2012</year>) <volume>12</volume>:<page-range>136&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3152</pub-id>, PMID: <pub-id pub-id-type="pmid">22266691</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>YJ</given-names></name>
<name><surname>Abila</surname> <given-names>B</given-names></name>
<name><surname>Mostafa Kamel</surname> <given-names>Y</given-names></name>
</person-group>. 
<article-title>CAR-T: what is next</article-title>? <source>Cancers</source>. (<year>2023</year>) <volume>15</volume>(<issue>3</issue>):<fpage>663</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers15030663</pub-id>, PMID: <pub-id pub-id-type="pmid">36765623</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ord&#xf3;&#xf1;ez-Reyes</surname> <given-names>C</given-names></name>
<name><surname>Garcia-Robledo</surname> <given-names>JE</given-names></name>
<name><surname>Chamorro</surname> <given-names>DF</given-names></name>
<name><surname>Mosquera</surname> <given-names>A</given-names></name>
<name><surname>Sussmann</surname> <given-names>L</given-names></name>
<name><surname>Ruiz-Pati&#xf1;o</surname> <given-names>A</given-names></name>
<etal/>
</person-group>. 
<article-title>Bispecific antibodies in cancer immunotherapy: A novel response to an old question</article-title>. <source>Pharmaceutics</source>. (<year>2022</year>) <volume>14</volume>(<issue>6</issue>):<fpage>1243</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pharmaceutics14061243</pub-id>, PMID: <pub-id pub-id-type="pmid">35745815</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sun</surname> <given-names>L</given-names></name>
<name><surname>Su</surname> <given-names>Y</given-names></name>
<name><surname>Jiao</surname> <given-names>A</given-names></name>
<name><surname>Wang</surname> <given-names>X</given-names></name>
<name><surname>Zhang</surname> <given-names>B</given-names></name>
</person-group>. 
<article-title>T cells in health and disease</article-title>. <source>Signal Transduction Targeted Ther</source>. (<year>2023</year>) <volume>8</volume>:<fpage>235</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-023-01471-y</pub-id>, PMID: <pub-id pub-id-type="pmid">37332039</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Borghans</surname> <given-names>JAM</given-names></name>
<name><surname>De Boer</surname> <given-names>RJ</given-names></name>
</person-group>. 
<article-title>Quantification of T-cell dynamics: from telomeres to DNA labeling</article-title>. <source>Immunol Rev</source>. (<year>2007</year>) <volume>216</volume>:<fpage>35</fpage>&#x2013;<lpage>47</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-065X.2007.00497.x</pub-id>, PMID: <pub-id pub-id-type="pmid">17367333</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fink</surname> <given-names>PJ</given-names></name>
</person-group>. 
<article-title>The biology of recent thymic emigrants</article-title>. <source>Annu Rev Immunol</source>. (<year>2013</year>) <volume>31</volume>:<fpage>31</fpage>&#x2013;<lpage>50</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-100010</pub-id>, PMID: <pub-id pub-id-type="pmid">23121398</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Restifo</surname> <given-names>NP</given-names></name>
<name><surname>Gattinoni</surname> <given-names>L</given-names></name>
</person-group>. 
<article-title>Lineage relationship of effector and memory T cells</article-title>. <source>Curr Opin Immunol</source>. (<year>2013</year>) <volume>25</volume>:<page-range>556&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coi.2013.09.003</pub-id>, PMID: <pub-id pub-id-type="pmid">24148236</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mahnke</surname> <given-names>YD</given-names></name>
<name><surname>Brodie</surname> <given-names>TM</given-names></name>
<name><surname>Sallusto</surname> <given-names>F</given-names></name>
<name><surname>Roederer</surname> <given-names>M</given-names></name>
<name><surname>Lugli</surname> <given-names>E</given-names></name>
</person-group>. 
<article-title>The who&#x2019;s who of T-cell differentiation: Human memory T-cell subsets</article-title>. <source>Eur J Immunol</source>. (<year>2013</year>) <volume>43</volume>:<page-range>2797&#x2013;809</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201343751</pub-id>, PMID: <pub-id pub-id-type="pmid">24258910</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Woodland</surname> <given-names>DL</given-names></name>
<name><surname>Kohlmeier</surname> <given-names>JE</given-names></name>
</person-group>. 
<article-title>Migration, maintenance and recall of memory T cells in peripheral tissues</article-title>. <source>Nat Rev Immunol</source>. (<year>2009</year>) <volume>9</volume>:<page-range>153&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri2496</pub-id>, PMID: <pub-id pub-id-type="pmid">19240755</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Montecino-Rodriguez</surname> <given-names>E</given-names></name>
<name><surname>Berent-Maoz</surname> <given-names>B</given-names></name>
<name><surname>Dorshkind</surname> <given-names>K</given-names></name>
</person-group>. 
<article-title>Causes, consequences, and reversal of immune system aging</article-title>. <source>J Clin Invest</source>. (<year>2013</year>) <volume>123</volume>:<page-range>958&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI64096</pub-id>, PMID: <pub-id pub-id-type="pmid">23454758</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>De Boer</surname> <given-names>RJ</given-names></name>
<name><surname>Yates</surname> <given-names>AJ</given-names></name>
</person-group>. 
<article-title>Modeling T cell fate</article-title>. <source>Annu Rev Immunol</source>. (<year>2023</year>) <volume>41</volume>:<page-range>513&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-101721-040924</pub-id>, PMID: <pub-id pub-id-type="pmid">37126420</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Macallan</surname> <given-names>DC</given-names></name>
<name><surname>Busch</surname> <given-names>R</given-names></name>
<name><surname>Asquith</surname> <given-names>B</given-names></name>
</person-group>. 
<article-title>Current estimates of T cell kinetics in humans</article-title>. <source>Curr Opin Syst Biol</source>. (<year>2019</year>) <volume>18</volume>:<fpage>77</fpage>&#x2013;<lpage>86</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coisb.2019.10.002</pub-id>, PMID: <pub-id pub-id-type="pmid">31922055</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Baliu-Piqu&#xe9;</surname> <given-names>M</given-names></name>
<name><surname>Tesselaar</surname> <given-names>K</given-names></name>
<name><surname>Borghans</surname> <given-names>JAM</given-names></name>
</person-group>. 
<article-title>Are homeostatic mechanisms aiding the reconstitution of the T-cell pool during lymphopenia in humans</article-title>? <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>1059481</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.1059481</pub-id>, PMID: <pub-id pub-id-type="pmid">36483556</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jain</surname> <given-names>A</given-names></name>
<name><surname>Sturmlechner</surname> <given-names>I</given-names></name>
<name><surname>Weyand</surname> <given-names>CM</given-names></name>
<name><surname>Goronzy</surname> <given-names>JJ</given-names></name>
</person-group>. 
<article-title>Heterogeneity of memory T cells in aging</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1250916</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1250916</pub-id>, PMID: <pub-id pub-id-type="pmid">37662959</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gossel</surname> <given-names>G</given-names></name>
<name><surname>Hogan</surname> <given-names>T</given-names></name>
<name><surname>Cownden</surname> <given-names>D</given-names></name>
<name><surname>Seddon</surname> <given-names>B</given-names></name>
<name><surname>Yates</surname> <given-names>AJ</given-names></name>
</person-group>. 
<article-title>Memory CD4 T cell subsets are kinetically heterogeneous and replenished from naive T cells at high levels</article-title>. <source>eLife</source>. (<year>2017</year>) <volume>6</volume>:<elocation-id>e23013</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.23013.028</pub-id>, PMID: <pub-id pub-id-type="pmid">28282024</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wade</surname> <given-names>AM</given-names></name>
<name><surname>Ades</surname> <given-names>AE</given-names></name>
</person-group>. 
<article-title>Age-related reference ranges: Significance tests for models and confidence intervals for centiles</article-title>. <source>Stat Med</source>. (<year>1994</year>) <volume>13</volume>:<page-range>2359&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/sim.4780132207</pub-id>, PMID: <pub-id pub-id-type="pmid">7855469</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schr&#xf6;ter</surname> <given-names>J</given-names></name>
<name><surname>Borghans</surname> <given-names>JAM</given-names></name>
<name><surname>Bitter</surname> <given-names>WM</given-names></name>
<name><surname>van Dongen</surname> <given-names>JJM</given-names></name>
<name><surname>de Boer</surname> <given-names>RJ</given-names></name><collab>collaboration with the EPIICAL Consortium</collab>
</person-group>. 
<article-title>Age-dependent normalization functions for T lymphocytes in healthy individuals</article-title>. <source>J Immunol</source>. (<year>2023</year>) <volume>210</volume>:<page-range>1882&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.2200520</pub-id>, PMID: <pub-id pub-id-type="pmid">37125851</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kulesh</surname> <given-names>V</given-names></name>
<name><surname>Peskov</surname> <given-names>K</given-names></name>
<name><surname>Helmlinger</surname> <given-names>G</given-names></name>
<name><surname>Bocharov</surname> <given-names>G</given-names></name>
</person-group>. 
<article-title>Systematic review and quantitative meta-analysis of age-dependent human T-lymphocyte homeostasis</article-title>. <source>Front Immunol</source>. (<year>2025</year>) <volume>16</volume>:<elocation-id>1475871</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2025.1475871</pub-id>, PMID: <pub-id pub-id-type="pmid">39931065</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brines</surname> <given-names>JK</given-names></name>
<name><surname>Gibson</surname> <given-names>JG</given-names></name>
<name><surname>Kunkel</surname> <given-names>P</given-names></name>
</person-group>. 
<article-title>The blood volume in normal infants and children</article-title>. <source>J Pediatrics</source>. (<year>1941</year>) <volume>18</volume>:<page-range>447&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0022-3476(41)80232-7</pub-id>, PMID: <pub-id pub-id-type="pmid">16693790</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Carrick-Ranson</surname> <given-names>G</given-names></name>
<name><surname>Hastings</surname> <given-names>JL</given-names></name>
<name><surname>Bhella</surname> <given-names>PS</given-names></name>
<name><surname>Shibata</surname> <given-names>S</given-names></name>
<name><surname>Fujimoto</surname> <given-names>N</given-names></name>
<name><surname>Palmer</surname> <given-names>D</given-names></name>
<etal/>
</person-group>. 
<article-title>The effect of age-related differences in body size and composition on cardiovascular determinants of VO2max</article-title>. <source>Journals Gerontology: Ser A</source>. (<year>2013</year>) <volume>68</volume>:<page-range>608&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/gerona/gls220</pub-id>, PMID: <pub-id pub-id-type="pmid">23160363</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sisson</surname> <given-names>TRC</given-names></name>
<name><surname>Whalen</surname> <given-names>LE</given-names></name>
</person-group>. 
<article-title>The blood volume of infants: III. Alterations in the first hours after birth</article-title>. <source>J Pediatrics</source>. (<year>1960</year>) <volume>56</volume>:<page-range>43&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0022-3476(60)80287-9</pub-id>, PMID: <pub-id pub-id-type="pmid">14447227</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Davy</surname> <given-names>KP</given-names></name>
<name><surname>Seals</surname> <given-names>DR</given-names></name>
</person-group>. 
<article-title>Total blood volume in healthy young and older men</article-title>. <source>J Appl Physiol</source>. (<year>1994</year>) <volume>76</volume>:<page-range>2059&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/jappl.1994.76.5.2059</pub-id>, PMID: <pub-id pub-id-type="pmid">8063668</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wakeham</surname> <given-names>DJ</given-names></name>
<name><surname>Hearon</surname> <given-names>CM</given-names></name>
<name><surname>Levine</surname> <given-names>BD</given-names></name>
</person-group>. 
<article-title>The effect of chronic habitual exercise on oxygen carrying capacity and blood compartment volumes in older adults</article-title>. <source>J Appl Physiol</source>. (<year>2024</year>) <volume>136</volume>:<page-range>984&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/japplphysiol.00706.2023</pub-id>, PMID: <pub-id pub-id-type="pmid">38420680</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zisowsky</surname> <given-names>J</given-names></name>
<name><surname>Krause</surname> <given-names>A</given-names></name>
<name><surname>Dingemanse</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Drug development for pediatric populations: regulatory aspects</article-title>. <source>Pharmaceutics</source>. (<year>2010</year>) <volume>2</volume>:<page-range>364&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pharmaceutics2040364</pub-id>, PMID: <pub-id pub-id-type="pmid">27721363</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kendall</surname> <given-names>MD</given-names></name>
<name><surname>Johnson</surname> <given-names>HR</given-names></name>
<name><surname>Singh</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>The weight of the human thymus gland at necropsy</article-title>. <source>J Anat</source>. (<year>1980</year>) <volume>131</volume>:<page-range>483&#x2013;97</page-range>., PMID: <pub-id pub-id-type="pmid">7216915</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Boyd</surname> <given-names>E</given-names></name>
</person-group>. 
<article-title>The weight of the thymus gland in health and in disease</article-title>. <source>Am J Dis Children</source>. (<year>1932</year>) <volume>43</volume>:<page-range>1162&#x2013;214</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/archpedi.1932.01950050114011</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kulesh</surname> <given-names>V</given-names></name>
<name><surname>Peskov</surname> <given-names>K</given-names></name>
<name><surname>Helmlinger</surname> <given-names>G</given-names></name>
<name><surname>Bocharov</surname> <given-names>G</given-names></name>
</person-group>. 
<article-title>An integrative mechanistic model of thymocyte dynamics</article-title>. <source>Front Immunol</source>. (<year>2024</year>) <volume>15</volume>:<elocation-id>1321309</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2024.1321309</pub-id>, PMID: <pub-id pub-id-type="pmid">38469297</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>van Gent</surname> <given-names>R</given-names></name>
<name><surname>SChadenberg</surname> <given-names>AWL</given-names></name>
<name><surname>Otto</surname> <given-names>SA</given-names></name>
<name><surname>Nievelstein</surname> <given-names>RAJ</given-names></name>
<name><surname>Sieswerda</surname> <given-names>GT</given-names></name>
<name><surname>Haas</surname> <given-names>F</given-names></name>
<etal/>
</person-group>. 
<article-title>Long-term restoration of the human T-cell compartment after thymectomy during infancy: a role for thymic regeneration</article-title>? <source>Blood</source>. (<year>2011</year>) <volume>118</volume>:<page-range>627&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2011-03-341396</pub-id>, PMID: <pub-id pub-id-type="pmid">21628415</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Silva</surname> <given-names>SL</given-names></name>
<name><surname>Albuquerque</surname> <given-names>AS</given-names></name>
<name><surname>Matoso</surname> <given-names>P</given-names></name>
<name><surname>Charmeteau-de-Muylder</surname> <given-names>B</given-names></name>
<name><surname>Cheynier</surname> <given-names>R</given-names></name>
<name><surname>Ligeiro</surname> <given-names>D</given-names></name>
<etal/>
</person-group>. 
<article-title>IL-7-induced proliferation of human naive CD4 T-cells relies on continued thymic activity</article-title>. <source>Front Immunol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>20</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.00020</pub-id>, PMID: <pub-id pub-id-type="pmid">28154568</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>van Hoeven</surname> <given-names>V</given-names></name>
<name><surname>Drylewicz</surname> <given-names>J</given-names></name>
<name><surname>Westera</surname> <given-names>L</given-names></name>
<name><surname>den Braber</surname> <given-names>I</given-names></name>
<name><surname>Mugwagwa</surname> <given-names>T</given-names></name>
<name><surname>Tesselaar</surname> <given-names>K</given-names></name>
<etal/>
</person-group>. 
<article-title>Dynamics of recent thymic emigrants in young adult mice</article-title>. <source>Front Immunol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>933/full</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.00933/full</pub-id>, PMID: <pub-id pub-id-type="pmid">28824653</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Haines</surname> <given-names>CJ</given-names></name>
<name><surname>Giffon</surname> <given-names>TD</given-names></name>
<name><surname>Lu</surname> <given-names>LS</given-names></name>
<name><surname>Lu</surname> <given-names>X</given-names></name>
<name><surname>Tessier-Lavigne</surname> <given-names>M</given-names></name>
<name><surname>Ross</surname> <given-names>DT</given-names></name>
<etal/>
</person-group>. 
<article-title>Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function</article-title>. <source>J Exp Med</source>. (<year>2009</year>) <volume>206</volume>:<page-range>275&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20080996</pub-id>, PMID: <pub-id pub-id-type="pmid">19171767</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vrisekoop</surname> <given-names>N</given-names></name>
<name><surname>den Braber</surname> <given-names>I</given-names></name>
<name><surname>de Boer</surname> <given-names>AB</given-names></name>
<name><surname>Ruiter</surname> <given-names>AFC</given-names></name>
<name><surname>Ackermans</surname> <given-names>MT</given-names></name>
<name><surname>van der Crabben</surname> <given-names>SN</given-names></name>
<etal/>
</person-group>. 
<article-title>Sparse production but preferential incorporation of recently produced na&#xef;ve T cells in the human peripheral pool</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2008</year>) <volume>105</volume>:<page-range>6115&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0709713105</pub-id>, PMID: <pub-id pub-id-type="pmid">18420820</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Richman</surname> <given-names>DD</given-names></name>
</person-group>. 
<article-title>Normal physiology and HIV pathophysiology of human T-cell dynamics</article-title>. <source>J Clin Invest</source>. (<year>2000</year>) <volume>105</volume>:<page-range>565&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI9478</pub-id>, PMID: <pub-id pub-id-type="pmid">10712427</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Michie</surname> <given-names>CA</given-names></name>
<name><surname>McLean</surname> <given-names>A</given-names></name>
<name><surname>Alcock</surname> <given-names>C</given-names></name>
<name><surname>Beverley</surname> <given-names>PCL</given-names></name>
</person-group>. 
<article-title>Lifespan of human lymphocyte subsets defined by CD45 isoforms</article-title>. <source>Nature</source>. (<year>1992</year>) <volume>360</volume>:<page-range>264&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/360264a0</pub-id>, PMID: <pub-id pub-id-type="pmid">1436108</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Macallan</surname> <given-names>DC</given-names></name>
<name><surname>Asquith</surname> <given-names>B</given-names></name>
<name><surname>Irvine</surname> <given-names>AJ</given-names></name>
<name><surname>Wallace</surname> <given-names>DL</given-names></name>
<name><surname>Worth</surname> <given-names>A</given-names></name>
<name><surname>Ghattas</surname> <given-names>H</given-names></name>
<etal/>
</person-group>. 
<article-title>Measurement and modeling of human T cell kinetics</article-title>. <source>Eur J Immunol</source>. (<year>2003</year>) <volume>33</volume>:<page-range>2316&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.200323763</pub-id>, PMID: <pub-id pub-id-type="pmid">12884307</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Macallan</surname> <given-names>DC</given-names></name>
<name><surname>Wallace</surname> <given-names>D</given-names></name>
<name><surname>Zhang</surname> <given-names>Y</given-names></name>
<name><surname>de Lara</surname> <given-names>C</given-names></name>
<name><surname>Worth</surname> <given-names>AT</given-names></name>
<name><surname>Ghattas</surname> <given-names>H</given-names></name>
<etal/>
</person-group>. 
<article-title>Rapid turnover of effector&#x2013;memory CD4+ T cells in healthy humans</article-title>. <source>J Exp Med</source>. (<year>2004</year>) <volume>200</volume>:<page-range>255&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20040341</pub-id>, PMID: <pub-id pub-id-type="pmid">15249595</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wallace</surname> <given-names>DL</given-names></name>
<name><surname>Zhang</surname> <given-names>Y</given-names></name>
<name><surname>Ghattas</surname> <given-names>H</given-names></name>
<name><surname>Worth</surname> <given-names>A</given-names></name>
<name><surname>Irvine</surname> <given-names>A</given-names></name>
<name><surname>Bennett</surname> <given-names>AR</given-names></name>
<etal/>
</person-group>. 
<article-title>Direct measurement of T cell subset kinetics <italic>in vivo</italic> in elderly men and women1</article-title>. <source>J Immunol</source>. (<year>2004</year>) <volume>173</volume>:<page-range>1787&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.173.3.1787</pub-id>, PMID: <pub-id pub-id-type="pmid">15265909</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mueller-Schoell</surname> <given-names>A</given-names></name>
<name><surname>Puebla-Osorio</surname> <given-names>N</given-names></name>
<name><surname>Michelet</surname> <given-names>R</given-names></name>
<name><surname>Green</surname> <given-names>MR</given-names></name>
<name><surname>K&#xfc;nkele</surname> <given-names>A</given-names></name>
<name><surname>Huisinga</surname> <given-names>W</given-names></name>
<etal/>
</person-group>. 
<article-title>Early survival prediction framework in CD19-specific CAR-T cell immunotherapy using a quantitative systems pharmacology model</article-title>. <source>Cancers</source>. (<year>2021</year>) <volume>13</volume>(<issue>11</issue>):<fpage>2782</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers13112782</pub-id>, PMID: <pub-id pub-id-type="pmid">34205020</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schubert</surname> <given-names>R</given-names></name>
<name><surname>Reichenbach</surname> <given-names>J</given-names></name>
<name><surname>Royer</surname> <given-names>N</given-names></name>
<name><surname>Pichler</surname> <given-names>M</given-names></name>
<name><surname>Zielen</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT)</article-title>. <source>Clin Exp Immunol</source>. (<year>2000</year>) <volume>119</volume>:<page-range>140&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2249.2000.01098.x</pub-id>, PMID: <pub-id pub-id-type="pmid">10606975</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mclean</surname> <given-names>AR</given-names></name>
<name><surname>Michie</surname> <given-names>CA</given-names></name>
</person-group>. 
<article-title><italic>In vivo</italic> estimates of division and death rates of human T lymphocytes</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>1995</year>) <volume>92</volume>:<page-range>3707&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.92.9.3707</pub-id>, PMID: <pub-id pub-id-type="pmid">7731969</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kaech</surname> <given-names>SM</given-names></name>
<name><surname>Wherry</surname> <given-names>EJ</given-names></name>
<name><surname>Ahmed</surname> <given-names>R</given-names></name>
</person-group>. 
<article-title>Effector and memory T-cell differentiation: implications for vaccine development</article-title>. <source>Nat Rev Immunol</source>. (<year>2002</year>) <volume>2</volume>:<page-range>251&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri778</pub-id>, PMID: <pub-id pub-id-type="pmid">12001996</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bajaria</surname> <given-names>SH</given-names></name>
<name><surname>Webb</surname> <given-names>G</given-names></name>
<name><surname>Cloyd</surname> <given-names>M</given-names></name>
<name><surname>Kirschner</surname> <given-names>D</given-names></name>
</person-group>. 
<article-title>Dynamics of naive and memory CD4+ T lymphocytes in HIV-1 disease progression</article-title>. <source>J Acquir Immune Defic Syndr</source>. (<year>2002</year>) <volume>30</volume>:<fpage>41</fpage>&#x2013;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.1097/00042560-200205010-00006</pub-id>, PMID: <pub-id pub-id-type="pmid">12048362</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sprent</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Circulating T and B lymphocytes of the mouse: I. Migratory properties</article-title>. <source>Cell Immunol</source>. (<year>1973</year>) <volume>7</volume>:<fpage>10</fpage>&#x2013;<lpage>39</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0008-8749(73)90180-9</pub-id>, PMID: <pub-id pub-id-type="pmid">4540428</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sprent</surname> <given-names>J</given-names></name>
<name><surname>Basten</surname> <given-names>A</given-names></name>
</person-group>. 
<article-title>Circulating T and B lymphocytes of the mouse: II</article-title>. <source>Lifespan. Cell Immunol</source>. (<year>1973</year>) <volume>7</volume>:<fpage>40</fpage>&#x2013;<lpage>59</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0008-8749(73)90181-0</pub-id>, PMID: <pub-id pub-id-type="pmid">4540431</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mandl</surname> <given-names>JN</given-names></name>
<name><surname>Liou</surname> <given-names>R</given-names></name>
<name><surname>Klauschen</surname> <given-names>F</given-names></name>
<name><surname>Vrisekoop</surname> <given-names>N</given-names></name>
<name><surname>Monteiro</surname> <given-names>JP</given-names></name>
<name><surname>Yates</surname> <given-names>AJ</given-names></name>
<etal/>
</person-group>. 
<article-title>Quantification of lymph node transit times reveals differences in antigen surveillance strategies of na&#xef;ve CD4+ and CD8+ T cells</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2012</year>) <volume>109</volume>:<page-range>18036&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1211717109</pub-id>, PMID: <pub-id pub-id-type="pmid">23071319</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ribeiro</surname> <given-names>RM</given-names></name>
<name><surname>Mohri</surname> <given-names>H</given-names></name>
<name><surname>Ho</surname> <given-names>DD</given-names></name>
<name><surname>Perelson</surname> <given-names>AS</given-names></name>
</person-group>. 
<article-title><italic>In vivo</italic> dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted</article-title>? <source>Proc Natl Acad Sci</source>. (<year>2002</year>) <volume>99</volume>:<page-range>15572&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.242358099</pub-id>, PMID: <pub-id pub-id-type="pmid">12434018</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Biancotto</surname> <given-names>A</given-names></name>
<name><surname>Iglehart</surname> <given-names>SJ</given-names></name>
<name><surname>Vanpouille</surname> <given-names>C</given-names></name>
<name><surname>Condack</surname> <given-names>CE</given-names></name>
<name><surname>Lisco</surname> <given-names>A</given-names></name>
<name><surname>Ruecker</surname> <given-names>E</given-names></name>
<etal/>
</person-group>. 
<article-title>HIV-1&#x2013;induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo</article-title>. <source>Blood</source>. (<year>2008</year>) <volume>111</volume>:<fpage>699</fpage>&#x2013;<lpage>704</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2007-05-088435</pub-id>, PMID: <pub-id pub-id-type="pmid">17909079</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Ganusov</surname> <given-names>VV</given-names></name>
<name><surname>Tomura</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Experimental and mathematical approaches to quantify recirculation kinetics of lymphocytes</article-title>. In: 
<person-group person-group-type="editor">
<name><surname>Molina-Par&#xed;s</surname> <given-names>C</given-names></name>
<name><surname>Lythe</surname> <given-names>G</given-names></name>
</person-group>, editors. <source>Mathematical, Computational and Experimental T Cell Immunology</source>. 
<publisher-name>Springer International Publishing</publisher-name>, <publisher-loc>Cham</publisher-loc> (<year>2021</year>). p. <page-range>151&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-030-57204-4_10</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sprent</surname> <given-names>J</given-names></name>
<name><surname>Miller</surname> <given-names>JFAP</given-names></name>
</person-group>. 
<article-title>Fate of H2-activated T lymphocytes in syngeneic hosts: II. Residence in recirculating lymphocyte pool and capacity to migrate to allografts</article-title>. <source>Cell Immunol</source>. (<year>1976</year>) <volume>21</volume>:<page-range>303&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0008-8749(76)90058-7</pub-id>, PMID: <pub-id pub-id-type="pmid">769995</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Perelson</surname> <given-names>AS</given-names></name>
<name><surname>Wiegel</surname> <given-names>FW</given-names></name>
</person-group>. 
<article-title>Scaling aspects of lymphocyte trafficking</article-title>. <source>J Theor Biol</source>. (<year>2009</year>) <volume>257</volume>:<fpage>9</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jtbi.2008.11.007</pub-id>, PMID: <pub-id pub-id-type="pmid">19084024</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rangarajan</surname> <given-names>A</given-names></name>
<name><surname>Weinberg</surname> <given-names>RA</given-names></name>
</person-group>. 
<article-title>Comparative biology of mouse versus human cells: modelling human cancer in mice</article-title>. <source>Nat Rev Cancer</source>. (<year>2003</year>) <volume>3</volume>:<page-range>952&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrc1235</pub-id>, PMID: <pub-id pub-id-type="pmid">14737125</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gattinoni</surname> <given-names>L</given-names></name>
<name><surname>Lugli</surname> <given-names>E</given-names></name>
<name><surname>Ji</surname> <given-names>Y</given-names></name>
<name><surname>Pos</surname> <given-names>Z</given-names></name>
<name><surname>Paulos</surname> <given-names>CM</given-names></name>
<name><surname>Quigley</surname> <given-names>MF</given-names></name>
<etal/>
</person-group>. 
<article-title>A human memory T cell subset with stem cell&#x2013;like properties</article-title>. <source>Nat Med</source>. (<year>2011</year>) <volume>17</volume>:<page-range>1290&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm.2446</pub-id>, PMID: <pub-id pub-id-type="pmid">21926977</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Osum</surname> <given-names>KC</given-names></name>
<name><surname>Jenkins</surname> <given-names>MK</given-names></name>
</person-group>. 
<article-title>Toward a general model of CD4+ T cell subset specification and memory cell formation</article-title>. <source>Immunity</source>. (<year>2023</year>) <volume>56</volume>:<page-range>475&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2023.02.010</pub-id>, PMID: <pub-id pub-id-type="pmid">36921574</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sumpter</surname> <given-names>AL</given-names></name>
<name><surname>Holford</surname> <given-names>NHG</given-names></name>
</person-group>. 
<article-title>Predicting weight using postmenstrual age &#x2013; neonates to adults</article-title>. <source>Pediatr Anesthesia</source>. (<year>2011</year>) <volume>21</volume>:<page-range>309&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1460-9592.2011.03534.x</pub-id>, PMID: <pub-id pub-id-type="pmid">21320235</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Sokolov</surname> <given-names>V</given-names></name>
<name><surname>Peskov</surname> <given-names>K</given-names></name>
<name><surname>Helmlinger</surname> <given-names>G</given-names></name>
</person-group>. <source>A framework for quantitative systems pharmacology model execution</source>. <publisher-loc>Berlin, Heidelberg</publisher-loc>: 
<publisher-name>Springer Berlin Heidelberg</publisher-name>. (<year>2025</year>) p. <fpage>1</fpage>&#x2013;<lpage>46</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/164_2024_738</pub-id>, PMID: <pub-id pub-id-type="pmid">40111538</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Musuamba</surname> <given-names>FT</given-names></name>
<name><surname>Skottheim Rusten</surname> <given-names>I</given-names></name>
<name><surname>Lesage</surname> <given-names>R</given-names></name>
<name><surname>Russo</surname> <given-names>G</given-names></name>
<name><surname>Bursi</surname> <given-names>R</given-names></name>
<name><surname>Emili</surname> <given-names>L</given-names></name>
<etal/>
</person-group>. 
<article-title>Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility</article-title>. <source>CPT: Pharmacometrics Syst Pharmacol</source>. (<year>2021</year>) <volume>10</volume>:<page-range>804&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/psp4.12669</pub-id>, PMID: <pub-id pub-id-type="pmid">34102034</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bai</surname> <given-names>JPF</given-names></name>
<name><surname>Liu</surname> <given-names>G</given-names></name>
<name><surname>Zhao</surname> <given-names>M</given-names></name>
<name><surname>Wang</surname> <given-names>J</given-names></name>
<name><surname>Xiong</surname> <given-names>Y</given-names></name>
<name><surname>Truong</surname> <given-names>T</given-names></name>
<etal/>
</person-group>. 
<article-title>Landscape of regulatory quantitative systems pharmacology submissions to the U.S. Food and Drug Administration: An update report</article-title>. <source>CPT: Pharmacometrics Syst Pharmacol</source>. (<year>2024</year>) <volume>13</volume>:<page-range>2102&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/psp4.13208</pub-id>, PMID: <pub-id pub-id-type="pmid">39423143</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cucurull-Sanchez</surname> <given-names>L</given-names></name>
<name><surname>Chappell</surname> <given-names>MJ</given-names></name>
<name><surname>Chelliah</surname> <given-names>V</given-names></name>
<name><surname>Amy Cheung</surname> <given-names>SY</given-names></name>
<name><surname>Derks</surname> <given-names>G</given-names></name>
<name><surname>Penney</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>Best practices to maximize the use and reuse of quantitative and systems pharmacology models: recommendations from the United Kingdom quantitative and systems pharmacology network</article-title>. <source>CPT: Pharmacometrics Syst Pharmacol</source>. (<year>2019</year>) <volume>8</volume>:<page-range>259&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/psp4.12381</pub-id>, PMID: <pub-id pub-id-type="pmid">30667172</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Braakman</surname> <given-names>S</given-names></name>
<name><surname>Pathmanathan</surname> <given-names>P</given-names></name>
<name><surname>Moore</surname> <given-names>H</given-names></name>
</person-group>. 
<article-title>Evaluation framework for systems models</article-title>. <source>CPT: Pharmacometrics Syst Pharmacol</source>. (<year>2022</year>) <volume>11</volume>:<page-range>264&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/psp4.12755</pub-id>, PMID: <pub-id pub-id-type="pmid">34921743</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sender</surname> <given-names>R</given-names></name>
<name><surname>Weiss</surname> <given-names>Y</given-names></name>
<name><surname>Navon</surname> <given-names>Y</given-names></name>
<name><surname>Milo</surname> <given-names>I</given-names></name>
<name><surname>Azulay</surname> <given-names>N</given-names></name>
<name><surname>Keren</surname> <given-names>L</given-names></name>
<etal/>
</person-group>. 
<article-title>The total mass, number, and distribution of immune cells in the human body</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2023</year>) <volume>120</volume>:<elocation-id>e2308511120</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2308511120</pub-id>, PMID: <pub-id pub-id-type="pmid">37871201</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Marino</surname> <given-names>S</given-names></name>
<name><surname>Hogue</surname> <given-names>IB</given-names></name>
<name><surname>Ray</surname> <given-names>CJ</given-names></name>
<name><surname>Kirschner</surname> <given-names>DE</given-names></name>
</person-group>. 
<article-title>A methodology for performing global uncertainty and sensitivity analysis in systems biology</article-title>. <source>J Theor Biol</source>. (<year>2008</year>) <volume>254</volume>:<page-range>178&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jtbi.2008.04.011</pub-id>, PMID: <pub-id pub-id-type="pmid">18572196</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Asquith</surname> <given-names>B</given-names></name>
<name><surname>Debacq</surname> <given-names>C</given-names></name>
<name><surname>Macallan</surname> <given-names>DC</given-names></name>
<name><surname>Willems</surname> <given-names>L</given-names></name>
<name><surname>Bangham</surname> <given-names>CRM</given-names></name>
</person-group>. 
<article-title>Lymphocyte kinetics: the interpretation of labelling data</article-title>. <source>Trends Immunol</source>. (<year>2002</year>) <volume>23</volume>:<fpage>596</fpage>&#x2013;<lpage>601</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1471-4906(02)02337-2</pub-id>, PMID: <pub-id pub-id-type="pmid">12464572</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lahoz-Beneytez</surname> <given-names>J</given-names></name>
<name><surname>Schaller</surname> <given-names>S</given-names></name>
<name><surname>Macallan</surname> <given-names>D</given-names></name>
<name><surname>Eissing</surname> <given-names>T</given-names></name>
<name><surname>Niederalt</surname> <given-names>C</given-names></name>
<name><surname>Asquith</surname> <given-names>B</given-names></name>
</person-group>. 
<article-title>Physiologically based simulations of deuterated glucose for quantifying cell turnover in humans</article-title>. <source>Front Immunol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>474</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.00474</pub-id>, PMID: <pub-id pub-id-type="pmid">28487698</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Costa del Amo</surname> <given-names>P</given-names></name>
<name><surname>Debebe</surname> <given-names>B</given-names></name>
<name><surname>Razavi-Mohseni</surname> <given-names>M</given-names></name>
<name><surname>Nakaoka</surname> <given-names>S</given-names></name>
<name><surname>Worth</surname> <given-names>A</given-names></name>
<name><surname>Wallace</surname> <given-names>D</given-names></name>
<etal/>
</person-group>. 
<article-title>The rules of human T cell fate <italic>in vivo</italic></article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>573</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.00573</pub-id>, PMID: <pub-id pub-id-type="pmid">32322253</pub-id>
</mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Goronzy</surname> <given-names>JJ</given-names></name>
<name><surname>Weyand</surname> <given-names>CM</given-names></name>
</person-group>. 
<article-title>Mechanisms underlying T cell ageing</article-title>. <source>Nat Rev Immunol</source>. (<year>2019</year>) <volume>19</volume>:<page-range>573&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-019-0180-1</pub-id>, PMID: <pub-id pub-id-type="pmid">31186548</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname> <given-names>H</given-names></name>
<name><surname>Weyand</surname> <given-names>CM</given-names></name>
<name><surname>Goronzy</surname> <given-names>JJ</given-names></name>
</person-group>. 
<article-title>Hallmarks of the aging T-cell system</article-title>. <source>FEBS J</source>. (<year>2021</year>) <volume>288</volume>:<page-range>7123&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/febs.15770</pub-id>, PMID: <pub-id pub-id-type="pmid">33590946</pub-id>
</mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Westera</surname> <given-names>L</given-names></name>
<name><surname>van Hoeven</surname> <given-names>V</given-names></name>
<name><surname>Drylewicz</surname> <given-names>J</given-names></name>
<name><surname>Spierenburg</surname> <given-names>G</given-names></name>
<name><surname>van Velzen</surname> <given-names>JF</given-names></name>
<name><surname>de Boer</surname> <given-names>RJ</given-names></name>
<etal/>
</person-group>. 
<article-title>Lymphocyte maintenance during healthy aging requires no substantial alterations in cellular turnover</article-title>. <source>Aging Cell</source>. (<year>2015</year>) <volume>14</volume>:<page-range>219&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/acel.12311</pub-id>, PMID: <pub-id pub-id-type="pmid">25627171</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Huenecke</surname> <given-names>S</given-names></name>
<name><surname>Behl</surname> <given-names>M</given-names></name>
<name><surname>Fadler</surname> <given-names>C</given-names></name>
<name><surname>Zimmermann</surname> <given-names>SY</given-names></name>
<name><surname>Bochennek</surname> <given-names>K</given-names></name>
<name><surname>Tramsen</surname> <given-names>L</given-names></name>
<etal/>
</person-group>. 
<article-title>Age-matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis</article-title>. <source>Eur J Haematology</source>. (<year>2008</year>) <volume>80</volume>:<page-range>532&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0609.2008.01052.x</pub-id>, PMID: <pub-id pub-id-type="pmid">18284628</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Steinmann</surname> <given-names>GG</given-names></name>
<name><surname>Klaus</surname> <given-names>B</given-names></name>
<name><surname>M&#xfc;ller-Hermelink</surname> <given-names>HK</given-names></name>
</person-group>. 
<article-title>The involution of the ageing human thymic epithelium is independent of puberty</article-title>. <source>Scandinavian J Immunol</source>. (<year>1985</year>) <volume>22</volume>:<page-range>563&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-3083.1985.tb01916.x</pub-id>, PMID: <pub-id pub-id-type="pmid">4081647</pub-id>
</mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>de Boer</surname> <given-names>RJ</given-names></name>
<name><surname>Tesselaar</surname> <given-names>K</given-names></name>
<name><surname>Borghans</surname> <given-names>JAM</given-names></name>
</person-group>. 
<article-title>Better safe than sorry: Naive T-cell dynamics in healthy ageing</article-title>. <source>Semin Immunol</source>. (<year>2023</year>) <volume>70</volume>:<fpage>101839</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.smim.2023.101839</pub-id>, PMID: <pub-id pub-id-type="pmid">37716048</pub-id>
</mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sauce</surname> <given-names>D</given-names></name>
<name><surname>Larsen</surname> <given-names>M</given-names></name>
<name><surname>Fastenackels</surname> <given-names>S</given-names></name>
<name><surname>Roux</surname> <given-names>A</given-names></name>
<name><surname>Gorochov</surname> <given-names>G</given-names></name>
<name><surname>Katlama</surname> <given-names>C</given-names></name>
<etal/>
</person-group>. 
<article-title>Lymphopenia-driven homeostatic regulation of naive T cells in elderly and thymectomized young adults</article-title>. <source>J Immunol</source>. (<year>2012</year>) <volume>189</volume>:<page-range>5541&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1201235</pub-id>, PMID: <pub-id pub-id-type="pmid">23136199</pub-id>
</mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cavalcanti</surname> <given-names>NV</given-names></name>
<name><surname>Palmeira</surname> <given-names>P</given-names></name>
<name><surname>Jatene</surname> <given-names>MB</given-names></name>
<name><surname>de Barros Dorna</surname> <given-names>M</given-names></name>
<name><surname>Carneiro-Sampaio</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Early thymectomy is associated with long-term impairment of the immune system: A systematic review</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>774780</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.774780</pub-id>, PMID: <pub-id pub-id-type="pmid">34899730</pub-id>
</mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>van den Broek</surname> <given-names>T</given-names></name>
<name><surname>Madi</surname> <given-names>A</given-names></name>
<name><surname>Delemarre</surname> <given-names>EM</given-names></name>
<name><surname>SChadenberg</surname> <given-names>AWL</given-names></name>
<name><surname>Tesselaar</surname> <given-names>K</given-names></name>
<name><surname>Borghans</surname> <given-names>JAM</given-names></name>
<etal/>
</person-group>. 
<article-title>Human neonatal thymectomy induces altered B-cell responses and autoreactivity</article-title>. <source>Eur J Immunol</source>. (<year>2017</year>) <volume>47</volume>:<page-range>1970&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201746971</pub-id>, PMID: <pub-id pub-id-type="pmid">28691750</pub-id>
</mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liang</surname> <given-names>Z</given-names></name>
<name><surname>Dong</surname> <given-names>X</given-names></name>
<name><surname>Zhang</surname> <given-names>Z</given-names></name>
<name><surname>Zhang</surname> <given-names>Q</given-names></name>
<name><surname>Zhao</surname> <given-names>Y</given-names></name>
</person-group>. 
<article-title>Age-related thymic involution: Mechanisms and functional impact</article-title>. <source>Aging Cell</source>. (<year>2022</year>) <volume>21</volume>:<elocation-id>e13671</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/acel.13671</pub-id>, PMID: <pub-id pub-id-type="pmid">35822239</pub-id>
</mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Taves</surname> <given-names>MD</given-names></name>
<name><surname>Ashwell</surname> <given-names>JD</given-names></name>
</person-group>. 
<article-title>Effects of sex steroids on thymic epithelium and thymocyte development</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>975858</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.975858</pub-id>, PMID: <pub-id pub-id-type="pmid">36119041</pub-id>
</mixed-citation>
</ref>
<ref id="B76">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Costa del Amo</surname> <given-names>P</given-names></name>
<name><surname>Lahoz-Beneytez</surname> <given-names>J</given-names></name>
<name><surname>Boelen</surname> <given-names>L</given-names></name>
<name><surname>Ahmed</surname> <given-names>R</given-names></name>
<name><surname>Miners</surname> <given-names>KL</given-names></name>
<name><surname>Zhang</surname> <given-names>Y</given-names></name>
<etal/>
</person-group>. 
<article-title>Human TSCM cell dynamics <italic>in vivo</italic> are compatible with long-lived immunological memory and stemness</article-title>. <source>PLoS Biol</source>. (<year>2018</year>) <volume>16</volume>:<elocation-id>e2005523</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pbio.2005523v</pub-id>, PMID: <pub-id pub-id-type="pmid">29933397</pub-id>
</mixed-citation>
</ref>
<ref id="B77">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Koftori</surname> <given-names>D</given-names></name>
<name><surname>Kaur</surname> <given-names>C</given-names></name>
<name><surname>Mora Bitria</surname> <given-names>L</given-names></name>
<name><surname>Zhang</surname> <given-names>Y</given-names></name>
<name><surname>Hadcocks</surname> <given-names>L</given-names></name>
<name><surname>Yan</surname> <given-names>AWC</given-names></name>
<etal/>
</person-group>. 
<article-title>Two distinct subpopulations of human stem-like memory T cells exhibit complementary roles in self-renewal and clonal longevity</article-title>. <source>PLoS Biol</source>. (<year>2025</year>) <volume>23</volume>:<elocation-id>e3003179</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pbio.3003179</pub-id>, PMID: <pub-id pub-id-type="pmid">40540506</pub-id>
</mixed-citation>
</ref>
<ref id="B78">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Szabo</surname> <given-names>PA</given-names></name>
<name><surname>Miron</surname> <given-names>M</given-names></name>
<name><surname>Farber</surname> <given-names>DL</given-names></name>
</person-group>. 
<article-title>Location, location, location: Tissue resident memory T cells in mice and humans</article-title>. <source>Sci Immunol</source>. (<year>2019</year>) <volume>4</volume>(<issue>34</issue>):<elocation-id>eaas9673</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciimmunol.aas9673</pub-id>, PMID: <pub-id pub-id-type="pmid">30952804</pub-id>
</mixed-citation>
</ref>
<ref id="B79">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sathaliyawala</surname> <given-names>T</given-names></name>
<name><surname>Kubota</surname> <given-names>M</given-names></name>
<name><surname>Yudanin</surname> <given-names>N</given-names></name>
<name><surname>Turner</surname> <given-names>D</given-names></name>
<name><surname>Camp</surname> <given-names>P</given-names></name>
<name><surname>Thome</surname> <given-names>JJC</given-names></name>
<etal/>
</person-group>. 
<article-title>Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets</article-title>. <source>Immunity</source>. (<year>2013</year>) <volume>38</volume>:<page-range>187&#x2013;97</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2012.09.020</pub-id>, PMID: <pub-id pub-id-type="pmid">23260195</pub-id>
</mixed-citation>
</ref>
<ref id="B80">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>M&#xe1;rquez</surname> <given-names>EJ</given-names></name>
<name><surname>Chung</surname> <given-names>CH</given-names></name>
<name><surname>Marches</surname> <given-names>R</given-names></name>
<name><surname>Rossi</surname> <given-names>RJ</given-names></name>
<name><surname>Nehar-Belaid</surname> <given-names>D</given-names></name>
<name><surname>Eroglu</surname> <given-names>A</given-names></name>
<etal/>
</person-group>. 
<article-title>Sexual-dimorphism in human immune system aging</article-title>. <source>Nat Commun</source>. (<year>2020</year>) <volume>11</volume>:<fpage>751</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-020-14396-9</pub-id>, PMID: <pub-id pub-id-type="pmid">32029736</pub-id>
</mixed-citation>
</ref>
<ref id="B81">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Conway</surname> <given-names>J</given-names></name>
<name><surname>A Duggal</surname> <given-names>N</given-names></name>
</person-group>. 
<article-title>Ageing of the gut microbiome: Potential influences on immune senescence and inflammageing</article-title>. <source>Ageing Res Rev</source>. (<year>2021</year>) <volume>68</volume>:<fpage>101323</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.arr.2021.101323</pub-id>, PMID: <pub-id pub-id-type="pmid">33771720</pub-id>
</mixed-citation>
</ref>
<ref id="B82">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shah</surname> <given-names>DK</given-names></name>
<name><surname>Betts</surname> <given-names>AM</given-names></name>
</person-group>. 
<article-title>Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human</article-title>. <source>J Pharmacokinet Pharmacodynamics</source>. (<year>2012</year>) <volume>39</volume>:<fpage>67</fpage>&#x2013;<lpage>86</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10928-011-9232-2</pub-id>, PMID: <pub-id pub-id-type="pmid">22143261</pub-id>
</mixed-citation>
</ref>
<ref id="B83">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cakala-Jakimowicz</surname> <given-names>M</given-names></name>
<name><surname>Kolodziej-Wojnar</surname> <given-names>P</given-names></name>
<name><surname>Puzianowska-Kuznicka</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Aging-related cellular, structural and functional changes in the lymph nodes: A significant component of immunosenescence</article-title>? <source>Overview. Cells</source>. (<year>2021</year>) <volume>10</volume>(<issue>11</issue>):<elocation-id>3148</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells10113148</pub-id>, PMID: <pub-id pub-id-type="pmid">34831371</pub-id>
</mixed-citation>
</ref>
<ref id="B84">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname> <given-names>LL</given-names></name>
<name><surname>Chen</surname> <given-names>X</given-names></name>
<name><surname>Cheng</surname> <given-names>JP</given-names></name>
</person-group>. 
<article-title>The effect of T cell aging on the change of human tissue structure</article-title>. <source>Immun Ageing</source>. (<year>2024</year>) <volume>21</volume>:<fpage>26</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12979-024-00433-4</pub-id>, PMID: <pub-id pub-id-type="pmid">38689298</pub-id>
</mixed-citation>
</ref>
<ref id="B85">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Malhotra</surname> <given-names>D</given-names></name>
<name><surname>Burrack</surname> <given-names>KS</given-names></name>
<name><surname>Jenkins</surname> <given-names>MK</given-names></name>
<name><surname>Frosch</surname> <given-names>AE</given-names></name>
</person-group>. 
<article-title>Antigen-specific CD4+ T cells exhibit distinct kinetic and phenotypic patterns during primary and secondary responses to infection</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>2125</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.02125</pub-id>, PMID: <pub-id pub-id-type="pmid">32983171</pub-id>
</mixed-citation>
</ref>
<ref id="B86">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chandler</surname> <given-names>J</given-names></name>
<name><surname>Bullock</surname> <given-names>ME</given-names></name>
<name><surname>Swain</surname> <given-names>AC</given-names></name>
<name><surname>Williams</surname> <given-names>C</given-names></name>
<name><surname>van Dorp</surname> <given-names>CH</given-names></name>
<name><surname>Seddon</surname> <given-names>B</given-names></name>
<etal/>
</person-group>. 
<article-title>Tissue-resident memory CD4+ T cells are sustained by site-specific levels of self-renewal and continuous replacement</article-title>. <source>eLife</source>. (<year>2025</year>) <volume>14</volume>:<fpage>RP104278</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.104278.3</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/790099">Peter S. Linsley</ext-link>, Benaroya Research Institute, United States</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1131475">Cangang Zhang</ext-link>, Xi&#x2019;an Jiaotong University, China</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1202157">Bernard Khor</ext-link>, Benaroya Research Institute, United States</p></fn>
</fn-group>
</back>
</article>